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ABSTRACT 
Over the last decade, scientists all over the world have profoundly used gene 
expression profiling based on microarray. Affymetrix is considered as the one of the 
pioneer platforms in the field of microarray technology. In this thesis, the Affymetrix 
Genechip® arrays were used to study the transcriptome of Tec family kinases with 
special emphasis on Bruton’s tyrosine kinase (Btk) in avian B-lymphoma DT40 cell-
line and fruit flies (Drosophila melanogaster). Btk is a protein tyrosine kinase 
belonging to the Tec family of kinases (TFKs). Btk is involved in signal transduction of 
the B cell receptor (BCR) pathway and plays an essential role in B lymphocyte 
development and function. X-linked agammaglobulinemia (XLA) is a primary 
immunodeficiency disease caused by mutations in the BTK gene. We studied Btk-
deficient DT40 avian cell line reconstituted with the human BTK gene in order to 
investigate whether the loss-of-function can be rescued by the gene substitution at the 
transcriptomic level. Differences in the gene expression pattern showed statistically 
significant changes between parental DT40 and all the Btk KO cell populations, 
irrespective of whether they are reconstituted or not. Our result showed clonal selection 
of Btk knockout and gene reconstituted cells. 
 
Btk is highly conserved during evolution appearing in sponges and in Drosophila 
melanogaster. In Drosophila, Btk29A (Btk family kinase at 29A) is the sole kinase that 
represents the Tec family, and it is most similar to Btk itself in terms of overall 
homology. In fact, the protein product from the type 2 splice variant of this gene 
exhibits the highest homology to Btk among the five mammalian TFKs. The type 1 
splice variant has a shorter N-terminus that is unique to Drosophila Btk29A. Btk29A 
displays a dynamic pattern of expression through the embryonic to adult stages. 
Btk29AficP is a unique allele in that it is devoid of the type 2 isoform while leaving type 
  
1 isoform intact. The Btk29AficP mutants survive to the adult stage, exhibiting a 
copulation defect and reduced lifespan after eclosion. We compared Btk mutant flies 
with their revertant strains using microarray gene expression profiling in adult brain 
and larvae CNS in order to investigate whether the loss-of-function phenotype can be 
rescued at the transcriptomic level. The whole transcriptomic profile for the different 
sample groups revealed Gene Ontology patterns for lifespan abnormalities in adult head 
neuronal tissue, but not in larval stage. We also carried out cross-species comparison in 
Btk-deficient flies and mice, which showed no significant overlap of the transcriptomic 
changes. Our results suggest that the evolutionary conservation is confined to 
components of the proximal signaling, whereas the corresponding, downstream 
transcriptional regulation has been differentially wired. 
 
In paper III (manuscript), we extended a previous study addressing the influence of 
another TFK, namely Itk, by investigating the influence of co-culture the interaction of 
CD4+ and CD8+ T cells, when they are separated or not in the context of T cell 
activation using expression profiling data. T cell activation is one of the important steps 
in the immune response where hundreds of genes and proteins play crucial roles in a 
highly organized manner. Activation of those genes in the immune system is dependent 
on the T cell receptor signaling pathway and its regulation of transcription. Our result 
shows 6% of the transcripts are influenced by the contact between CD4+ and CD8+ T 
cells. This finding is of general importance, since whenever T cells are cultivated, 
whether they are separated into subsets or not, influences the analysis of their 
transcriptomes. 
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LIST OF ABBREVIATIONS 
 
APC 
BAFF-R 
Antigen presenting cell 
B-cell activator of the TNF-a family –receptor 
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BLNK B-cell linker protein 
BM Bone marrow 
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IFN-γ                          Interferon-γ 
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JNK c-Jun N-terminal kinase 
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Mal MyD88 adapter-like protein 
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Myd88 Myeloid differentiation protein 88 
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NFAT Nuclear factor of activated T cell 
NF- κB Nuclear factor kappa B 
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PI3K Phosphoinositide 3 kinase 
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Rlk/Txk Resting lymphocyte kinase/T and X cell expressed kinase 
RMA Robust Multi-array average 
Sab SH3-domain binding protein 
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STAT Signal tranducer and activator of transcription 
Syk Spleen tyrosine kinase 
Tc Cytotoxic T cell 
TCR T-cell receptor 
Tec Tyrosine kinase expressed in hepatocellular carcinoma 
TFKs Tec family kinases 
TH Tec homology 
Th T helper cell 
TNF-β Tumor necrosis factor β  
TLR Toll like receptor 
Xid X-linked immunodeficiency 
XLA X-linked agammaglubulinemia 
Zap70 Zeta-chain-associated protein kinase 70 
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1 INTRODUCTION 
 
Recent development in bioinformatics and high-throughput technologies such as 
microarray analysis has made a revolution in the field of molecular medicine. This 
has a great impact on the discovery of new targets for the treatment of disease in form 
of drug development, immunotherapeutic and gene therapy.  Microarray studies and 
other genomic techniques have helped the scientists to understand mechanisms 
underlying normal and dysfunctional biological processes such as cancer, 
inflammation and immunodeficiency. This has now become an emerging discipline 
that integrates high-throughput expression profiling technology and systems biology 
approaches [1]. With the rapid advances of microarray analysis technologies, 
bioinformatics is extensively used in the studies of gene expression profiling, miRNA–
mRNA interactions, DNA–protein interactions and protein–protein interactions. 
Different microarray platforms have been developed so far is based on same 
principle: hybridization between two complementary strands of nucleic acid.  Purified 
RNA is fluorescently- or radioactively labeled and hybridized to the slide/membrane. 
After thorough washing, laser scanning obtains the raw data; the data may then be 
entered into a database and analyzed by a number of statistical methods with help of 
different bioinformatics tools [2]. 
 
In this thesis work, I have used microarray expression profiling in order to investigate 
transcriptional regulation in Tec family kinases with a special emphasis on Bruton’s 
tyrosine kinase (Btk) in chicken DT40 cell line as well as in fruit flies and 
transcriptional influence in activated primary mouse T cells. 
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1.1 Tec family kinases 
 
Tec family kinases (TFKs) form the second largest family of cytoplasmic tyrosine 
kinases in mammalian cells and include, in addition to Btk, Tec (Tyrosine kinase 
expressed in hepatocellular carcinoma), Itk (IL-2 inducible T cell kinase), Txk 
(Tyrosine protein kinase , also known as Rlk), and Bmx (bone marrow tyrosine kinase 
gene on chromosome X ) [3]. The name tyrosine kinase stems from the ability of these 
enzymes to phosphorylate tyrosine residues. The family has been so far described in 
mammals and semantics even in the unicellular organism Monosiga brevicollis [4].  
Most of the TFKs (Btk, Itk, Tec, Txk) are predominantly expressed in hematopoietic 
cells mostly in B and T lymphocytes, whereas Bmx is essentially restricted to 
endothelial cells [5-8]. In B cells, Btk and Tec are highly expressed; whereas T cells 
mostly express Itk, Tec and Rlk/Txk [9]. TFKs have been also showed to be expressed 
in the myeloid lineage in macrophages (Bmx, Btk and Tec), in neutrophils (Bmx, Btk 
and Tec), in mast cells (Btk, Itk and Tec) and in dendritic cells (Btk) [10]. These 
kinases are involved in a wide range of signaling pathways that control mitogen-
activated protein kinase (MAPK) activation, Ca2+ influx, actin reorganization, 
transcriptional regulation, cell survival and cellular transformation [11-15] 
 
Our group has previously shown that NF-kappaB (NF-κB) regulates the transcription 
Tec and identified a unique functionally active NF-κB binding site in its promoter [16]. 
Txk has also been shown to and regulate interferon-γ gene transcription in Th1 cells by 
forming a complex with poly (ADP-ribose) polymerase 1 and elongation factor 1α [17]. 
Itk has also been reported to interact physically with transcription factor TFII-I and 
potentiates TFII-I-driven c-fos transcription [18]. Role of Btk in transcriptional 
regulation is described in more details in later part. 
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1.2 Bruton’s tyrosine kinase (Btk) 
 
Expression of Btk has been detected at all stages of B-lymphocytes prior to the plasma 
cell stage [9]. Btk is also involved in mast cell activation [19]. It has been recently 
reported that Btk expression is up-regulated during maturation and activation of mouse 
Natural Killer (NK) cells [20] and is also important for effective osteoclastogenesis as 
its deficiency has resulted in incomplete osteoclast differentiation and mild 
osteopetrosis [21].  Btk is also known to play a dual role when it comes to survival and 
apoptosis [22]. Btk is highly conserved during evolution appearing in sponges and in 
Drosophila melanogaster and vertebrates [4]. A sign of the conservation is the fact that 
the human BTK gene can partly substitute for loss-of-function of the D. melanogaster 
Btk29A gene [23].  
 
X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disease caused 
by mutations in the BTK gene [9, 24-26], that was first described by Dr. Ogden Bruton 
in 1952.  Patients with XLA lack circulating B cells due to a complete block in their B 
lymphocyte development at the mature B cell stage[27, 28]. Therefore, patients have 
severe hypogammaglobulinemia and impaired antibody responses. This results in 
increased susceptibility to bacterial and enteroviral infections. The X-linked 
immunodeficiency (Xid) phenotype in mice is caused by a missense mutation (R28C) 
in the N-terminally located pleckstrin homology (PH) domain of Btk. Btk knockout 
(KO) mice, which lack detectable Btk protein, have an Xid-like phenotype [29]. Recent 
investigations also suggest the role of Btk in the development and BCR/TLR-
dependent activation of AM14 rheumatoid factor B cells and Btk deficiency only 
partially blocks the development of systemic autoimmune disease [30]. 
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1.3  BTK gene and transcription factors 
 
Btk gene was first cloned in 1992 in two different research groups in Europe and USA 
[24, 25]. The BTK gene is located on the human X chromosome at Xq21.3-Xq22 and 
consists of 19 exons spanning 37.5 kb of genomic DNA [31]. It has been reported that 
Btk may play a role in transcription in addition to its involvement in the signaling 
cascade from the BCR. Several laboratories, including ours [32], have shown that Btk 
affects downstream components of the BCR signaling pathway, thereby regulating 
gene expression. As an example, Btk has been shown to interact with several 
transcription factors, including nuclear factor of activated T cell (NFAT) and NF-κB 
[16, 33] implicating that it has a direct role in transcriptional regulation [34]. A review 
article from Wasif A. Khan, depicted that BTK is required for efficient induction of 
bcl-x transcription in response to BCR crosslinking which is regulated by NF-κB [35].  
 
Several other research groups have reported the role of BTK in transcriptional 
regulation. Among those are the transcription factor BAP-135/TFII-I [36] and Bright 
[33, 37]. Recently, it has been demonstrated that in addition to Btk, Bright can associate 
with TFII-I to induce immunoglobulin heavy chain transcription [34, 38]. Btk has also 
been shown to induce the transcriptional co-activation activity of the Btk-associated 
protein BAM 11[39]. Finally, Btk has been shown to phosphorylate signal transducer 
and activator of transcription 5A (STAT5A) in the chicken B-cell line DT-40 [40]. 
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1.4 Btk family kinase at 29A (Tec29) in Drosophila 
 
In Drosophila, Btk29A (Btk family kinase at 29A) is the sole kinase that represents the 
Tec family, and it is most similar to Btk itself in terms of overall homology. Btk29A 
is required for survival and male genital formation in Drosophila. fickleP (ficP), which 
removes the Btk homolog in Drosophila, was isolated in a screening of P-element 
mutants with defects in mating behavior [41]. Btk29A has splice variants (type 1 and 
type 2), generated by an alternative exon usage (Figure 1). Both the transcripts are 
expressed in the central nervous system (CNS) and imaginal discs; the domains 
and/or timing of expression in these tissues are distinct from each other. Complete 
loss-of-function of the gene (i.e., loss of both types 1 and 2) causes oocyte 
undergrowth and embryonic death accompanied by defective head involution [42-44], 
while selective loss of the type 2 transcripts spares life but reduces the life span in the 
adult and leads to malformation of the male genitalia [23].  It has been also reported 
that Btk-binding protein Sab (SH3-domain binding protein), a Src homology 3 
domain-binding protein inhibits the auto- and transphosphorylation activity of Btk 
and thus functions as a transregulator of Btk [45]. 
 
 
Figure 1: Structural comparison of Drosophila and human orthologs of Btk. 
Reproduced from Baba et al., 1999 [41]. 
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1.5 B cell receptor signaling 
 
The B cell antigen receptor (BCR) is composed of a transmembrane immunoglobulin 
heavy chain (IgH) and a covalently associated light chain (IgL) with two heterodimers 
Ig-α (CD79a) and Ig-β (CD79b) [46].  Ig-α and Ig-β each contain a unique 26 amino 
acid region immunoreceptor tyrosine-based activation motif (ITAM) in their 
cytoplasmic terminal domains which functions as a docking site for many of the signal 
transducing modular proteins during BCR cross-linking. This regulates the antigen 
recognition component and the signal transduction by BCR, which in turn modulates 
gene expression, adhesion or survival, thereby determining the fate of antigen-
encountered B cells [47]. 
 
The initial signaling pathways activated in response to BCR ligation involve multiple 
protein tyrosine kinase cascades such as Src family kinase Lyn, spleen tyrosine kinase 
(Syk), Bruton’s tyrosine kinase (Btk) and adaptor protein B-cell linker (BLNK) [48, 
49]. Btk is first phosphorylated by Lyn, at tyrosine 551[50], that leads to the activation 
of phospholipase C (PLC)- 2 that catalyzes the production of second messengers by 
hydrolysis of phosphatidylinositol-4,5-bisphosphate [PtdIns(4,5)P2] to diacylglycerol 
(DAG) and inositol-1,4,5-trisphosphate (IP3). IP3 binds to its receptor (IP3R) in the 
endoplasmic reticulum (ER) membrane, thereby causing a rapid release of Ca2+ from 
ER stores [51]. These second messengers regulate calcium mobilization and activate 
the PKC isoenzymes that are essential for functional expression of transcription 
factors. 
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1.6 T cell biology and activation 
 
T cells are key effectors of the adaptive immune response as they play important roles 
in the immune defense and are major effectors in autoimmune diseases. T cell 
activation takes place upon ligation of T cell receptors (TCRs) by MHC molecules on 
antigen-presenting cells (APCs) (Figure 2). Itk, one of the family members of non-
receptor tyrosine kinases plays a crucial role for TCR –induced activation and IL-2 
production [12, 52]. Following antigen-receptor engagement in T cells, Itk induces 
tyrosine phosphorylation of PLCγ2 with subsequent production of IP3 and mobilization 
of intracellular Ca2+ from ER.  This in turn activates calmodulin and Ca2+  sensitive 
phosphatase Calcineurin  and regulates transcription factors such as NFAT [53].  
 
The SRC family kinase (SFK) members Lck and Fyn are the first molecules to be 
activated following TCR engagement [54-56]. SFKs are essential to provide the tonic 
signaling that is required for the survival of naïve T cells [57]. Lck is constitutively 
active in naïve T cells and maintains a basal level of phosphorylation on TCR-
associated ζ-chains [58]. Lck binds to the cytoplasmic domains of the TCR co-
receptors CD4 and CD8 [59]. Following interaction of the TCR with a peptide–MHC 
complex, these co-receptors are important for targeting the delivery of Lck into close 
proximity to its substrates: TCR-associated CD3 and ζ-chain immunoreceptor tyrosine-
based activation motifs (ITAMs) [60]. These targets of Lck including the tyrosine 
residues in the ITAMs of TCR-associated CD3γ chain, CD3δ chain, CD3ε chains and 
the ζ-chains, and the SYK family kinase Zap70 (ζ-chain associated protein kinase of 70 
kDa) get phosphorylated TCR[61].  This TCR 'signal triggering module' involves Lck-
dependent phosphorylation of the ITAMs, allowing the recruitment and the Lck-
dependent phosphorylation of Zap70 [62]. This aggregation and phosphorylation 
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results in conformational changes in Zap70, which promote its kinase activity, leading 
to the phosphorylation of its target molecules; including the key adaptor molecule 
linker for activation of T cells (Lat)  [63].  In turn, the phosphorylated tyrosine residues 
of Lat recruit multiple downstream adaptor and signaling molecules, which then 
activate several signaling cascades and exert cellular functions like cell adhesion; 
mobilization to the nucleus of transcription factors that are crucial for the expression of 
genes necessary for T cell growth and differentiation; and actin reorganization, which is 
essential for T cell activation, proliferation and adhesion. 
 
Itk is also important in signaling downstream of the T cell co-stimulatory receptor 
CD28 [64, 65]. CD28 is activated by B7-1 and B7-2 [66] and activates the Ser/Thr 
kinase protein kinase B which regulates the PI3K pathway [67]. The major signaling 
product of PI3K activity is phosphatidylinositol (3,4,5)-trisphosphate [PI(3,4,5)P3], 
which rapidly accumulates within cells following cellular stimulation. This molecule is 
largely responsible for the co-localization of 3′-phosphoinositide-dependent protein 
kinase (PDK)-1 and its substrate protein kinase B (PKB)–Akt at the plasma membrane, 
through interaction with their pleckstrin homology (PH) domains. PDK-1 
phosphorylates and activates the AGC kinase members including PKB–Akt, which is a 
key effector of PI3K signaling that is sufficient to co-stimulate interleukin (IL)-2 and 
interferon-γ production. Optimal T-cell activation requires T-cell receptor (TCR) 
signaling as well CD28 T-cell co-stimulatory molecule also known as ‘two-signal’ 
model of T-cell activation [68, 69]. 
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Figure 2: T cell receptor signaling. Reproduced from Readinger et al., 2009 [70]. 
 
 
1.6.1 CD4+ and CD8+ T cells 
 
CD4 and CD8 T cell surface molecules play a role in T cell recognition and activation 
by binding to their respective class II and class I major histocompatibility complex 
(MHC) ligands on an antigen presenting cell (APC). Naïve CD4+ and CD8+ T cells get 
activated in the peripheral lymphoid organs after receiving external signals or stimuli in 
order to proliferate and differentiate into effector and regulatory cells [71-73]. In vitro 
stimulation of T lymphocytes has been frequently used to expand specific cells present 
at low precursor frequency in vivo[74]. However, this technique might not reflect the in 
vivo situation because of the variable efficiency of outgrowth of different T cell sub-
populations [75]. Interaction of the CD4+/CD8+ lineages in the thymus is a complex 
process between these functional subsets[76]and their surface-phenotype is crucial for 
the entire immune response [77].   
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1.7 Global gene expression profiling 
 
Gene expression technology is currently a widely used and powerful tool of molecular 
biology for investigating the transcriptional behavior of biological systems as well as 
for classifying cell states in disease. There are to date over 750,000 gene expression 
data sets in the National Center for Biotechnology Information Gene Expression 
Omnibus (GEO) public database [78]. Global gene expression analysis uses DNA 
microarrays, RNA-Seq, and other methods to measure the levels of RNA species in 
biological systems [79-82]. Among those, DNA microarrays have been most frequently 
used for expression analysis and it consist of millions of individual oligonucleotide 
probes fixed to a solid surface. These oligonucleotide probes have sequences 
representative of known RNA species for the whole genome or a specific part of the 
genome and are generally used to quantitate the relative levels of RNA species that 
hybridize to the probes. More recently developed sequencing technologies known as 
Next-generation sequencing (NGS) also provide a measure of the frequency of RNA 
species through sequencing of RNA-derived cDNA populations [83-85]. There are also 
other approaches that have been developed in last few years such as digital molecular 
barcoding, which represents a fusion of the hybridization and counting approaches [86]. 
One mostly used platform is the Nanostring nCounter assay system which digitally 
quantifies the hybridization of labeled probes to RNA molecules and single-molecule 
imaging to provide a measurement of the frequency of particular RNA species [87]. 
 
1.7.1 Microarray expression profiling 
 
The very first article describing microarrays was published in 1995 by Brown and co-
workers [88] where they showed differential expression measurements of 45 
Arabidopsis thaliana genes using cDNA arrays. Previously described DNA 
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microarrays are small, solid supports onto which the sequences from thousands of 
different genes are immobilized, or attached, at fixed locations [89]. These are usually 
made by glass microscope slides, silicon chips, or nylon membranes where the DNA 
is printed or spotted [90]. Each spot contains one type of nucleic acid and each 
nucleic acid is a polymer of nucleotides of defined length. The nucleic acid on each 
spot differ from the other nucleic acids in the array in the sequence of the bases 
adenine (A), cytosin (C), guanine (G), and thymine (T) [91, 92]. DNA arrays are 
based on the specific base pairing of complementary nucleotides (A-T and C-G) 
leading to double-stranded sequences of nucleic acids. In cDNA microarrays, probes 
are usually with a length of 400–1,000 base pairs (bp), which leads to a high 
specificity for the targets. There are basically three types of samples that can be used to 
construct DNA microarrays, two are genomic and the other is "transcriptomic", that is, 
it measures mRNA levels. The target DNA used will also determine the type of control 
and sample DNA that is used in the hybridization solution [93, 94]. 
 
The oligonucleotides microarrays are more popular array platforms at present where 
the probes are with lengths <200 bp, up to short oligonucleotides of ~18-25 bases in 
case chips [95]. There are several commercially available arrays in the market and 
among those, Affymetrix, Agilent, Illumina and NimbleGen are the mostly used 
microarray platforms. Affymetrix has 25mer probes and are synthesized by 
Photolithographic technique [96, 97]. Agilent uses 60mer probes and synthesized by 
inject technology on glass slides [98]. Illumina has 50mer probes and they use bead 
technology [99]. NimbleGen uses 60mer probes that are synthesized on a glass slide 
[100] .  
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1.7.2 Affymetrix Genechip® technology 
 
One of the earliest descriptions of today’s most frequently used platform for 
expression profiling, Affymetrix GeneChips, is from 1996 [101] and many advances 
have been made over the last decade. Affymetrix Genechip technology brought 
revolution in the field of bio-medical research with their different types of arrays 
(Figure 3). Affymetrix provide two generations of expression arrays, 3' (IVT) and 1.0 
ST. 3' arrays were the first array type from Affymetrix, and are available for a large 
number of species. Classical 3’ expression microarrays are not able to discriminate 
between alternatively spliced transcripts that have identical 3’ ends. The combination 
of Affymetrix’ Whole Transcript (WT) Assay and high-density arrays, including 
GeneChip® Exon 1.0 ST Arrays and GeneChip® Gene 1.0 ST Arrays, provides a 
more complete and more accurate picture of overall gene expression. With 
approximately four probes per exon and roughly 40 probes per gene, the GeneChip® 
Human Exon 1.0 ST Array enables two complementary levels of analysis—gene 
expression and alternative splicing. The most advance is to date is the GeneChip® 
miRNA 2.0 array covering 71 organisms, including human, mouse, rat, and monkey.  
 
 Affymetrix use ‘Photolithographic’ technique where large-scale production of 
GeneChip probe arrays containing hundreds of thousands of oligonucleotide sequences 
on a glass "chip" about 1.5 cm2 in size can be possible. Due to their very high 
information content, GeneChip probe arrays are finding widespread use in the 
hybridization-based detection and analysis of mutations and polymorphisms 
("genotyping"), and in a wide range of gene expression studies [97]. 
 
 
  
  13 
 
 
Figure 3: Different types of Affymetrix arrays [102]. 
 
 
Affymetrix conventionally  uses several probe-sets for each transcript or genes and 
there are principally two types of probes: (1) probes that have complete 
complementarity to their target sequence [perfect match probe (PM)] and (2) probes 
with a single mismatch to the target, centered in the middle of the oligonucleotide 
[mismatch probe (MM)] (Figure 4). The PM/MM design is used for identification and 
subtraction of nonspecific hybridization and background signals[103]. MM probes are 
effective internal controls, since they will hybridize to nonspecific sequences about as 
effectively as their counterpart PM probes. This unique probe pairing strategy helps 
identify and subtract nonspecific hybridization and background signals. The new 
Exon arrays, Gene1.0 ST arrays, SNP 5.0, 6.0 arrays do not contain MM probes. 
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Figure 4: Basic principle of IVT arrays ( Re-produced from Dalma-Weiszhausz et al., 
2006) [104]. 
 
The target preparation protocols have several steps and the first step start with a 
purified nucleic acid sample, mostly RNA. The RNA is usually amplified and then 
labeled and fragmented consequently. The labeled RNA is then purified and 
fragmented by hydrolysis. The most widely used sample preparation for gene 
expression utilizes the IVT reaction as originally described by Eberwine and 
colleagues [105]. In this assay cDNA synthesis is initiated from an oligo(dT) primer 
that is also coupled to a T7 RNA polymerase primer and the cDNA synthesis starts 
adjacent to the poly(A) tail of the mRNA. After second strand synthesis, a 
double‐stranded cDNA copy of each mRNA is created attached to the T7 RNA 
polymerase primer. An IVT reaction is then carried out to create a biotinylated RNA 
target (Figure 5). A variation of this technique utilizes two rounds of IVT 
amplification and is used to create a target from very small amounts (100 ng or less) 
of starting material. 
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Figure 5: Schematic representation of array hybridization [www.affymetrix.com]. 
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1.7.3 Microarray data analysis 
After hybridization and washing, the chip is being scanned and the next step in 
analysis is the assignment of pixels that make up the image (.dat) file. Several 
methods have been developed so far and global gridding method is widely used for 
the Affymetrix array. In this method, the four corners of the array, defined by 
checkerboard patterns, serve as anchors for the grid. Features are then created by 
evenly dividing the area defined by the anchored corners into the known number of 
features for a given array. An additional step called Feature Extraction has been 
implemented to assign pixels to features in a more robust manner. This enhances the 
original pixels assigned to a feature that are shifted as a block, a pixel at a time, and 
calculate the coefficient of variation (CV) of pixel intensities. Following Feature 
Extraction the intensity of each feature is calculated and stored in a .CEL file [106]. 
 
Regardless of application, the feature intensities found in .CEL files are used by 
analysis software to detect sequence variation or to differentiate gene expression 
levels of transcripts. During analysis, the use of multiple probes per genotype or gene 
is combined with standard statistical methods to provide a transparent and robust 
conversion of probe intensities to biological information. 
 
1.7.4 Pre-processing of microarray data 
 
 Affymetrix chip pre-processing is normally a three-step procedure which include 
estimation of the background signal, possible background correction normalization, 
and summarizing the separate normalized probe measurements into a single value per 
probe set [107]. A variety of algorithms has been used to summarize multiple probe 
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intensities of a transcript in the experimental sample. ‘Detection calls’ are made by 
Affymetrix software through an arithmetic calculation of probe pairs within a set 
designed to detect a specific transcript (GeneChip MAS5.0 and GCOS software) 
[108]. More widely used summarization methods include Probe Logarithmic Intensity 
Error estimation (PLIER) [109], Model based expression method in DNA-chip 
analyzer (dChip) [110] and Robust Multi-array Average (RMA) [111]. 
 
 PLIER algorithm utilizes experimental data generated across multiple arrays in order 
to identify and account for observed patterns in probe intensities difference between 
probes by means of a parameter termed “probe affinity.” Probe affinities determine 
the signal intensity produced at a specific target concentration for a given probe, and 
are calculated using experimental data across multiple arrays. The Microarray Suite 
5.0 (MAS5.0) is the normalization method developed by Affymetrix. It makes use of 
the MM measurements to compute an Ideal Mismatch value and then corrects the PM 
values with these Ideal Mismatch values. MAS5.0 then uses a one-step Tukey 
Biweight algorithm as summarization method [112] . A new software application 
called GeneChip RNA EXpression Analysis (GREX) has  been introduced recently 
by Affymetrix that features in addition to MAS5.0 and PLIER: quantile 
normalization, Analysis of variance (ANOVA) for replicate analysis and integrated 
retrieval of NetAffx™  Analysis Center annotations for faster  identification of 
biological relevance [102]  .  
 
dChip normalizes arrays at PM and MM probe level before computing model-based 
expression levels. It then uses the Invariant Set Normalization method that is 
normalization of arrays based on an ‘invariant set’. The basic principle is that it chooses 
a subset of PM probes with small within-subset rank difference in the two arrays, to 
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serve as the basis for fitting a normalization curve [113, 114]. dChip uses an intensity-
modeling approach for data analysis and clusters microarray probe sets exhibiting 
similar expression profiles. In summary, normalization takes place across all the arrays 
using probes of ‘invariant set’ and ‘Running median’ smoothing with a ‘Model-based 
expression’ method  for PM-MM or ‘5th percentile of region (PM-only)’ as background 
subtractions. 
 
The Robust Multi-array Average (RMA) method, first introduced by Irizarry and his 
group, does not use the MM values [115]. The background is instead estimated by 
convoluting the signal and noise distributions from the PM values. After background 
correction, RMA performs quantile normalization and then uses median polish as 
summarization method. The quantile normalization method aims to make the 
distribution of probe intensities for each array the same for a set of arrays [116]. 
When applying the median polish algorithm to a matrix, one subtracts the row 
medians and then the column medians in an iterative manner. After convergence, the 
row and column medians are zero, and the remaining matrix is subtracted from the 
original data matrix. GCRMA [117]  is a modified RMA procedure and includes the 
GC content of the probes in the background adjustment step. 
 
1.7.5 Statistical and down-stream analysis 
 
After pre-processing of the microarray data, the next step is to identify groups of 
genes with specific expression patterns and relations across the samples. Hierarchical 
clustering  and principal components analysis (PCA) are the methods that are widely 
used [118]. Hierarchical clustering has the advantage that it is simple and the result 
can be easily visualized [119]. Hierarchical clustering is an agglomerative approach 
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in which single expression profiles are joined to form groups, which are further joined 
until the process has been carried to completion, forming a single hierarchical tree. 
PCA is a statistical technique for determining the key variables in a multidimensional 
data set that explain the differences in the observations, and can be used to simplify the 
analysis and visualization of multidimensional data sets [120]. PCA shows visual 
estimation of the number of clusters represented in the data which resembles whether 
genes that have similar, correlated patterns of expression [121].  
 
In order to identify genes that may be affected by a treatment or gene mutation, the 
simplest and most common experimental set-up is to compare two groups: for 
example, Treatment vs. Control, or Mutant vs. Wild type, mostly known as pair-wise 
comparison.  The most powerful and commonly used statistical test for comparing a 
single measure on two groups is the t-statistic, where one gets a p-value as an end 
result. A drawback of the t-statistic for microarray datasets is that most experiments 
have only a few samples in each group, and so the standard error is not very reliable 
as there is a risk for false positives. In such cases, one can compute the ratios of 
variances between groups (F-ratios), and comparing to an F-distribution where 
discrepancies in variance estimates are not too large for many of the genes that are 
selected as differentially expressed.  
 
Another way of addressing this is the Non-parametric tests such as Wilcoxon signed-
rank test that reflects the distribution of the gene expression values in a strictly 
symmetric fashion. Permutation testing is an approach that is widely applicable and 
copes with distributions that are far from Normal. Significance Analysis of 
Microarray (SAM) is s an interface that implements permutation testing [122, 123]. 
The meaning of a p-value from a permutation procedure differs from the meaning of a 
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model-based p-value. The model-based p-value is the probability of the test statistic, 
assuming that the gene levels in both the treatment and control groups follow the 
model.  
 
As mentioned above, t–test can give false positive values and for that, statistical 
filtering is used to specify the false discovery rate (FDR) described by Benjamini and 
Hochberg [124]. The false discovery rate is an estimate of the number of false 
positives relative to the number of all genes flagged as ‘positives’ by a procedure. In 
contrast the (single test) p-value is the probability of a false positive on that one test. 
In the context of multiple tests, it is an estimate of the number of false positives 
relative to the number of truly unchanged genes (all negatives). The true multi-test p-
value is the probability of seeing any false positives among all the tests being done. 
Another classical multiple testing procedures is the family-wise error rate (FWER) 
using Bonferroni correction has been used frequently for false positive results [125].  
FWER  measures the probability that the analysis yields any false positive findings but 
less used now a days due to its limitations being too conservative for the analysis of 
microarray data [126]. 
 
The q-value (also known as corrected p-value) is the smallest FDR at which a 
particular gene would just stay on the list of positives.  This is not identical to the p-
value, which is the smallest false positive rate (FPR) at which the gene appears 
positive. The p-value is much stricter than the q-value. Most of the researchers, who 
compute significance of genes by permutations, are actually computing the q-value, 
rather than the p-value [127]. 
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1.7.6 Gene ontology and Gene set enrichment analysis 
 
The next step is the interpretation of microarray data in a biological context. The Gene 
Ontology Consortium provides a controlled vocabulary to annotate the biological 
knowledge we have or that is predicted for a given gene. The Gene Ontologies (GOs) 
are organized as a hierarchy of annotation terms and the top‐level ontologies are 
molecular function, biological process, and cellular component [128]. The most 
commonly used methods to test for enrichment of a gene set is known as Gene set 
enrichment analysis (GSEA) for identifying over/under-representative GO term with a 
p-value or false discovery rate (FDR) [129]. The basic principle of this analysis is that a 
list of genes is selected from a microarray first, for example, by choosing all 
significantly differentially expressed genes using a cutoff value based on 
hypergeometric distribution and use either Fisher's exact test or the χ2 test. The test for 
enrichment involves counting how many genes in the gene set occur in the list of 
selected genes and how many occur on the microarray, and then estimating what 
proportion of genes from the gene set would be expected to appear in randomly 
selected lists.  
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2 AIMS 
General aim: The general aim of this thesis work was to identify the role of Btk at the 
transcriptional level using microarray gene expression analysis, whereas the specific 
aims of this research were: 
 
1. To define the distinct gene expression signature  in Btk defective cells 
2. To perform cross-species studies (Meta-analysis) 
3. To investigate the influence of co-culture of different T cell subsets and 
their activation. 
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3 MATERIALS AND METHODS 
 
3.1 DT40 cell-line 
 
DT40 is an avian leucosis virus-transformed chicken B-lymphocyte line and is widely 
used as model system for making gene-targeted mutants. Homologous DNA 
recombination-controlled gene conversion technique is used here for modification of 
genetic loci in vertebrate somatic cells [130]. The cell-lines used in Paper I, were the 
parental DT40, Btk knockout, B7.10; Btk KO reconstituted with human wild type 
Btk, B41.13 or kinase-inactive Btk, B46.5 were generated in Dr. T. Kurosaki’s 
laboratory at RIKEN Research Center for Allergy and Immunology in Japan [131]. The 
cells were cultured in RPMI 1640 Glutamax medium with 10% FBS, 1% chicken 
serum, Penicillin-Streptomycin, 4 mM glutamine, and 50 μM 2-mercaptoethanol (2-
ME) starting in 1 ml serum-free medium for 15 min at 37 °C with 5% CO2. 
Stimulations were during that time done with 5 μl supernatant of the hybridoma cell-
line M4 (a kind gift from Dr Max D. Cooper, University of Birmingham, AL). After 
15 min incubation, 49 ml medium was added and cells were cultivated for 2, 6 or 24 h 
with, or without, stimuli. 
 
3.2 Primary T cell separation and stimulation 
 
Scientists have successfully separated sub-populations of T cell in last few decades 
using different methods [132, 133]. With advancement of immunofluorescence and 
flow cytometry techniques, isolation of T cell has become an easier and routine method 
[134, 135]. Both positive and negative selection methods have been developed in order 
to isolate purified T cell sub-sets [136]. In Paper III, T-cells were isolated from 
suspensions of spleen and lymph nodes of C57BL/6 mice. CD3+, CD4+ and CD8+ T 
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cells were then isolated by negative selection method [137, 138]. The cell suspensions 
were incubated with the antibodies in PBS supplemented with 2% FCS. Streptavidin 
beads (BD Pharmingen) were used for negative depletion according to manufacturer's 
instructions. The purity of the cells was assessed by flow cytometry and was routinely 
>90% CD3+, >96% CD4+ and >90% CD8+ T-cells. Separated T cells subsets (CD3+, 
CD4+ and CD8+) were stimulated with anti-CD3 (1 μg/ml) for 24 h in 48-well plates.   
 
3.3 Drosophila melanogaster  
 
The fruit fly, Drosophila melanogaster , is a well-studied model organism that is 
investigated extensively in the twentieth century for understanding molecular 
mechanisms of human diseases as many basic biological, physiological, and 
neurological properties are conserved between mammals and D. melanogaster [139, 
140].  Approximately, 75% of human disease-causing genes are believed to have a 
functional homolog in the fly [141] and has contributed substantially to further 
investigate the process of cancer genetics and therapeutic drug discovery [142].  In 
Paper II, we used Btk defective fruit flies, w;Btk29AficP/CyO and w1118; Btk29A(fic 
Exc1–16)/SM1 were generated in the Yamamoto laboratory [143]. Flies were raised on 
standard medium on a 12:12 h L:D cycle, at 23 °C and at 55% RH. Flies were 
anaesthetized using CO2, then immediately dissected under microscope. The tissues 
dissected were the complete heads, severed at the neck from adult flies and the CNS 
(developing brain), including the optic lobes from third instar wandering stage larvae. 
Tissues were collected into RLT buffer, pooled and extracted for RNA. 
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3.4 RNA isolation 
 
Different commercially available RNA extraction kits have made RNA isolation more 
easier and time efficient. In this study, total RNA was extracted with RNeasy Mini Kit 
(Qiagen, Valencia, CA, USA). The RNA amount and the quality were measured 
primarily with a NanoDrop spectrophotometer (Wilmington, USA) [144] and then in an 
Agilent Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA) at the 
Affymetrix core facility before hybridization. Agilent uses an RNA integrity number 
(RIN) to get a robust and reliable prediction of RNA integrity, thus checking the quality 
of the RNA [145]. For Paper I, five micrograms of total RNA from each of the ten 
replicates (per sample) were pooled and hybridized to Genechip® Chicken Genome 
arrays. For Paper II-III, 100 ng of total RNA was amplified according to Affyemtrix 
Small Sample protocol with two rounds of IVT [146].  
 
3.5 Affymetrix Genechip® array 
 
In Paper I, Genechip® Chicken Genome array containing 32,773 transcripts 
corresponding to over 28,000 chicken genes was used. In total, 28 arrays were 
generated as a pool of 10 different replicates in each. In Paper II, Drosophila genome 
2 expression arrays comprised of 18,880 probe sets, analyzing over 18,500 transcripts 
were hybridized and read using standard Affymetrix procedures. In total there were 12 
arrays which include three replicates for Btk29AficP and Btk29A(fic Exc1–16) sample groups 
(the larval CNS and adult heads). In Paper III, The GeneChip® Mouse Genome 430 
2.0 Array covering the Mouse Expression Set 430 for analysis of over 39,000 
transcripts on a single array were used. In total 10 arrays were analyzed which are 
accessible through the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/).  
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Microarrays were run at the Bioinformatics and Expression Analysis core facility 
(http://apt.bea.ki.se/index.html) located at Karolinska Institutet, Huddinge (Novum). 
 
3.6 Data analysis and bioinformatics 
 
In Paper I, pre-processing of microarray data was carried out using Affymetrix® 
Expression Console software.  Data were normalized across all the arrays using probes 
of ‘Invariant set’ and ‘Running median’ smoothing. Model-based expression values 
were obtained using ‘Model-based expression’ method and ‘5th percentile of region 
(PM-only)’ as background using dChip. The genes were filtered according to the 
variation across samples: 0.20 < Standard deviation/mean < 100.00. 8,835 of 38,439 
probe sets satisfied the filtering criteria. In addition, the upper and lower threshold ratio 
was set to 1.8 while performing pair-wise comparisons. Hierarchical clustering of the 
gene expression profile was performed using Pearson’s correlation with a threshold of 
p < 0.005 for calling significant clusters. Cluster dendrogram was generated in ‘R’ 
(www.r-project.org). Three different sets of mouse B-cell data [147-149] were 
converted into chicken orthologs using the Netaffx®. Data are deposited in GEO with 
an accession number (GSE12466). 
 
In Paper II, raw data were pre-processed using R statistical programming language, 
Bioconductor (http://www.bioconductor.org/), and the ‘affy’ package. Data were 
initially RMA normalized first across the samples and then within each sample group. 
RMA normalized data were then scaled to a common median value. Both raw and 
pre-processed data is deposited in GEO (GSE30627). Further filtering, within sample 
group analyses and pair-wise comparisons were carried out using dChip 
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(https://sites.google.com/site/dchipsoft/, http://biosun1.harvard.edu/complab/dchip/) 
and Microsoft Excel. 
 
In Paper III, The pre-processing of the data was performed using MAS5.0 algorithm in 
the Affymetrix Expression Array Console. The pre-processed data were filtered upon 
the assessed as background value criteria that were set as 50. Assessment of 
background value was based upon the number of ‘Absent call’ in all the probe sets. 
Additional filtering was done after taking away the Affymetrix control gene –AFFX. In 
total 19,112 probe-sets fulfilled the criteria. Further analyses were carried out using 
Subio Platform (http://www.subio.jp/ ).  Pairwise comparisons were carried out using 
different statistical methods in three T cell subsets. For the CD3+ T cells, F-test was 
performed in order to verify the variance in the replicates, T test of equal variance was 
chosen as the statistical method with a fold change of +/-2 and false discovery rate 
(FDR) 0.05. For the CD4+ populations, variance testing methods were applied with a 
with a fold change of +/-2.  In the CD8+ population, since there is only a single sample, 
only fold change of +/-2 was chosen for differentially expressed genes. In total 10 arrays 
were analyzed which are accessible through the Gene Expression Omnibus (GEO; 
GSE12466). 
 
3.7 PCR and DNA sequencing 
 
Conventional PCR technique is a widely used method in molecular biology used for 
amplifying DNA sequences [150]. PCR products can  be directly sequenced by various 
of  methods using fluorophore-labeled sequencing primers [151]. In Paper II, four kb 
(2L:8274950,8279050) surrounding the Btk29A-locus in drosophila genome was 
used as a template to construct 8 forward-, and 8 reverse oriented primers covering 
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the entire 4-kb region from both ends with a 500 bp spacing. Primers were also made 
for the 3´- and 5´-ends of the Btk29AficP -responsible P-element (Bm∆-w). Both 
primers were facing outwards from the P-element. PCR was performed using ABI 
GeneAmpTM system 2700 and the insertion site was determined by sequencing the 
PCR product (http://www.eurofinsdna.com). 
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4 RESULTS AND DISCUSSION 
 
4.1 Paper I 
Expression profiling of chicken DT40 lymphoma cells indicates clonal selection of 
knockout and gene reconstituted cells 
 
The DT40 cell-line has been extensively used to create deletion mutants, one of which 
lacks Bruton's tyrosine kinase (Btk). It was previously shown that there are differences 
in gene expression between wild-type and Btk-deficient animals [147, 148]. Global 
gene expression profiling of the avian B-lymphoma DT40 cell-line was used as a model 
to differentiate among Btk knockout (KO) and Btk KO cells reconstituted with human 
Btk. We observed that there was substantial difference in the expression pattern 
between Wt DT40 and Btk KO B7.10 cells. However, the human Btk-reconstituted 
B41.13 was more similar towards its parental cell-line (Btk KO B7.10) than towards 
DT40 cells. The same effect was observed in Btk KO cells reconstituted with kinase-
inactive human Btk. It is likely that this reflects the much higher degree of clonal 
selection, which takes place during the generation of deletion mutants as compared to 
cell-lines reconstituted by transfection. Differences in the gene expression pattern 
showed statistically significant changes between parental DT40 and all the Btk KO cell 
populations irrespective of whether they are reconstituted or not. These results imply 
that in the process of generating a knockout cell-line, sub-clones are selected, which 
have multiple changes in their gene expression pattern (p<0.01). Although other 
parameters could also influence the expression profile, this potentially has important 
implications when interpreting microarray data from gene-deleted cell-lines. 
 
DT40 cell-line has been used as a model for the study of proximal signaling events 
[152, 153]. It has been previously shown that chicken KO cells reconstituted with a 
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human BTK gene have the same functional activity as parental DT40 cells, when 
analyzing membrane-proximal signaling events [154, 155]. In this study, the cell-
lines were compared to each other in order to verify the degree of clonal selection 
among the deletion mutants. We observed that the clonal selection is the dominant 
underlying factor, in contrast to proximal events, when transcriptional patterns were 
investigated using microarray gene expression profiling. 
 
 
4.2 Paper II 
Differential evolutionary wiring of the tyrosine kinase Btk. 
 
Btk29A is considered to be the fly ortholog of Bruton’s tyrosine kinase (Btk), a non-
receptor-type tyrosine kinase of the Tec family. In contrast to the mammalian Tec gene 
family that is composed of five members, Drosophila has only one Tec family gene, 
Btk29A, with two splice variants-type 1 and type 2. In fact, the protein product from the 
type 2 splice variant of this gene exhibits the highest homology to Btk among the five 
mammalian Tec kinases. The type 1 splice variant has a shorter N-terminus that is 
unique to Drosophila Btk29A. Btk29A displays a dynamic pattern of expression 
through the embryonic to adult stages. Btk29AficP is a unique allele in that it is devoid of 
the type 2 isoform while leaving type 1 isoform intact. The Btk29AficP mutants survive 
through to the adult stage, exhibiting a copulation defect and reduced lifespan after 
eclosion. We used Affymetrix® Drosophila Genome 2.0 Genechip arrays containing 
18, 770 transcripts - corresponding to the vast majority of known Drosophila genes. We 
mainly focused on the central nervous tissue as it is known that Btk 29A is mostly 
expressed in these tissues. It is also known that reduced adult lifespan phenotypes are 
associated with the selective loss of the type 2 isoform, which represents the Btk 
ortholog. We carried out micro-dissection of the CNS tissue from both adult and larval 
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stage of Btk29AficP   flies and the revertant strain ficExc.1-16 in order to check whether the 
loss-of-function phenotype can be rescued at the transcriptomic level. 
 
Out of 7,004-7,979 transcripts expressed in the four sample groups; 5,587 (70-79%) 
were found in all four tissues and strains. Here, we investigated the role of Btk29A type 
2 on a transcriptomic level in larval CNS and adult heads. We used samples either 
selectively defective in Btk29A type 2 Btk29AficP   or revertant flies with restored 
Btk29A type 2-function ficExc.1-16. The whole transcriptomic profile for the different 
sample groups revealed Gene Ontology patterns reflecting lifespan abnormalities in 
adult head neuronal tissue, but not in larvae. In the Btk29A type 2-deficient strains 
there was no significant overlap between transcriptomic alterations in adult heads and 
larvae neuronal tissue, respectively. Moreover, there was no significant overlap of the 
transcriptomic changes between flies and mammals, suggesting that the evolutionary 
conservation is confined to components of the proximal signaling, whereas the 
corresponding, downstream transcriptional regulation has been differentially wired. 
 
 
4.3 Paper III 
Estimating the influence of CD4+ CD8+ T cell interactions on the transcriptome 
 
T cell activation is one of the important steps in the immune response where hundreds 
of genes and proteins play crucial roles in a highly organized manner. Activation of 
those genes in the immune system is dependent on the T cell receptor signaling 
pathway and its regulation of transcription [156]. Most of the research laboratories 
follow the more conventional method and separate lymphocytes before activation. In 
this study, we show that this may not be the optimal way since the separated cells show 
some altered gene expression profile.  
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We used mouse Affymetrix® MOE 430_2.0 array containing over 45,000 probe-sets 
and selected around 10,000 probe-sets those were differentially expressed in compare 
to un-stimulated cells upon activation in CD4+, CD8+ and CD3+ T cells. Expression of 
6% of all genes was found to be dependent on CD4+-CD8+ interactions. Gene set 
enrichment analysis (GSEA) of these genes revealed 22 overrepresented Gene 
Ontology (GO) Biological processes. Among those ‘adaptive immune response’ and 
‘lymphocyte/leucocyte mediated immunity’ were of interest in the context of T cell 
activation. We also observed similar expression pattern in genes involved in immune 
response and T cell activation compared to the global expression profiling. . Our results 
shows that there is has no such major influence on the induced transcriptomes in the 
context in vitro T cell culture when it is separated first and then activated. 
 
 
 
 
 
  
  33 
 
5 CONCLUDING REMARKS 
 
Microarray gene expression profiling has been regarded as one the most powerful tools 
in molecular medicine for more than a decade. A huge amount of data can be generated 
and analyzed from a single experiment and that can be compared with archived data all 
across the globe. Our group has been working with expression profiling of Btk 
deficiency in primary B cells and Itk deficiency in primary T cells which is eventually 
complemented with this thesis work. Exploring the chicken cell lines and the 
Drosophila as a model organism has changed our concept of thinking when it comes to 
transcriptomic activation. Cross-species studies revealed much dissimilarity in different 
scenarios in the context of Btk deficiency. Regulation of T cell activation has also been 
addressed in this work, which might help the scientist to design their experiments in 
future. Technology advances fast with time and sooner or later, easy availability of the 
RNA sequencing might take over growing field of microarray expression profiling. 
Works done in this thesis will hopefully add more knowledge for the scientists working 
with cell lines and cell activation in the context of transcriptional influence. 
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journal  homepage:  www.elsevier.com/ locate /ybbrcMuta tions affect ing Bru ton’s tyro sine kinase (Btk) cause dis rup-
tion in B-lym pho cyte devel op ment, lead ing to X-linked aga mma-
glob u lin emia (XLA) in humans [1,2] and the less severe X-linked 
immu no de fi ciency (Xid) in mice [3,4]. Mice defi cient in both Btk 
and the related kinase Tec have an XLA-like phe no type [5]. Btk is a 
non-recep tor tyro sine kinase belong ing to the Tec fam ily [6–8]. Btk 
fea tures, from the N-ter mi nal, a PH domain, a Tec homol ogy (TH) 
and Src homol ogy domains 3 (SH3), 2 (SH2), and 1 (SH1) [9]. Muta-
tions affect ing any of Btk’s domains cause XLA and the strik ing fea-
ture of B-cells lack ing func tional Btk is that they fail to expand. Btk 
is highly con served dur ing evo lu tion appear ing in the uni cel lu lar 
cho a no flag el late Mo nos i ga brev i col lis [10] and also found in Dro­
soph ila mel a no gas ter [11] and other ver te brates. A sign of the con-
ser va tion is the fact that the human BTK gene can partly substitute 
for loss-of-func tion of the D. mel a no gas ter Btk29A gene [12].
Expres sion pro fil ing has enhanced the under stand ing of cel-
lu lar sig nal ing mol e cules and their down stream tar gets in health 
and dis ease. Btk-defi ciency is ideal for expres sion pro fil ing, since 
the defect is intrin sic to the B-cell line age. To deter mine effects 
on the tran scrip tome, we used the Af fyme trix Gene chip® micro-
array tech nol ogy to com pare avian DT40 cells with Btk KO as well 
as dele tion mutants recon sti tuted with Btk. Overt dif fer ences in 
the expres sion pattern were observed. How ever, they did not seg-
re gate accord ing to the pres ence and absence of func tional Btk, but 
instead as a result of clonal selec tion. This poten tially has impor-
tant impli ca tions for the use of micro array anal y sis of cell-lines 
and sug gests that this issue should be sub ject to fur ther stud ies.
Mate ri als and meth ods
Cell­lines: DT40 cell-lines were gen er ated in Dr. T. Kuro sa ki’s 
lab o ra tory at RI KEN Research Cen ter for Allergy and Immu nol ogy 
in Japan [13]. The cell-lines used in this study were the paren tal 
DT40, Btk knock out, B7.10; Btk KO recon sti tuted with human wild-
type Btk, B41.13 or kinase-inac tive Btk, B46.5.
Cell cul ture: The DT40 cells were cul tured in RPMI 1640 Gluta max 
medium with 10% FBS, 1% chicken serum, Pen i cil lin-Strep to my cin, 
4 mM glu ta mine, and 50 lM 2-mercap toethanol (2-ME). DT40 and 
B7.10 cells were cul ti vated in three dif fer ent fetal calf serum batches, 
while B41.13 and B46.5 were grown in a sin gle serum batch. Both 
un-stim u lated and stim u lated cells were grown in the same way, 
start ing in 1 ml serum-free medium for 15 min at 37 °C with 5% CO2. 
Stim u la tions were dur ing that time done with 5 ll super na tant of 
the hybrid oma cell-line M4 (a kind gift from Dr Max D. Coo per, Uni-
ver sity of Bir ming ham, AL). After 15 min incu ba tion, 49 ml medium 
was added and cells were cul ti vated for 2, 6 or 24 h with, or with out, 
stim uli. In total the exper i ment was repeated ten times and rep li-
cates were pooled prior to expres sion pro fil ing.
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The DT40 cell-line has been exten sively used to cre ate dele tion mutants, one of which lacks Bru ton’s 
tyro sine kinase (Btk). Btk is a cyto plas mic tyro sine kinase impor tant for B-lym pho cyte mat u ra tion. It 
was pre vi ously shown that there are dif fer ences in gene expres sion between wild-type and Btk-defi cient 
ani mals. Global gene expres sion pro fil ing of the avian B-lym phoma DT40 cell-line was used as a model 
to dif fer en ti ate among Btk knock out (KO) and Btk KO cells recon sti tuted with human Btk. Dif fer ences in 
the gene expres sion pattern showed sta tis ti cally sig nifi  cant changes between paren tal DT40 and all the 
Btk KO cell pop u la tions irre spec tive of whether they are recon sti tuted or not. These results imply that in 
the pro cess of gen er at ing a knock out cell-line, sub-clones are selected, which have multiple changes in 
their gene expres sion pattern (p < 0.01). Although other param e ters could also influ ence the expres sion 
pro file, this poten tially has impor tant impli ca tions when inter pret ing micro array data from gene-deleted 
cell-lines.
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RNA iso la tion and oli go nu cleo tide array hybrid iza tion: Total RNA 
was extracted with RNeasy Mini Kit (Qiagen, Valen cia, CA, USA). 
The RNA amount and the qual ity were mea sured with a Nano Drop 
spec tro pho tom e ter (Wil ming ton, USA) and an Ag i lent Bio an a-
lyzer 2100 (Ag i lent Tech nol o gies, Palo Alto, CA, USA). Five micro-
grams from each of the ten rep li cates (per sam ple) were pooled 
and hybrid ized to Chicken Genome arrays Gene chips®; in total 28 
arrays were run. The cRNA syn the sis and hybrid iza tions were per-
formed in the BEA core facil ity at Depart ment of Bio sci ences, Kar-
o linska In sti tu tet at Novum, Hudd in ge, Swe den.
Data and sta tis ti cal anal y sis strat egy for gene selec tion: In order to 
opti mize the use of micro array chips, all the 28 sam ples were gen-
er ated as a pool of 10 dif fer ent rep li cates in each [14–16]. Qual ity 
con trol (QC) was checked using Af fyme trix® Expres sion Con sole 
soft ware. In order to find dis tinct pat terns in our data set, DNA-
Chip Ana lyzer “dChip” (www.dchip.org) was exer cised [17]. dChip 
uses an inten sity-mod el ing approach for data anal y sis and clus ters 
micro array probe sets exhib it ing sim i lar expres sion pro files. Data 
were nor mal ized across all the arrays using probes of ‘invari ant 
set’ and ‘Run ning median’ smooth ing. Model-based expres sion 
val ues were obtained using ‘Model-based expres sion’ method and 
‘5th per cen tile of region (PM-only)’ as back ground. The genes were 
fil tered accord ing to the var i a tion across sam ples: 0.20 < Stan dard 
devi a tion/mean < 100.00. 8,835 of 38,439 probe sets sat is fied the 
fil ter ing cri te ria. In addi tion, the upper and lower thresh old ratio 
was set to 1.8 while performing pair-wise com par i sons. Hier ar chi-
cal clus ter ing of the gene expres sion pro file was per formed using 
Pear son’s cor re la tion with a thresh old of p < 0.005 for call ing sig nifi -
cant clus ters. Clus ter den dro gram was gen er ated in ‘R’ (www.r-pro-
ject.org). Three dif fer ent sets of mouse B-cell data were con verted 
into chicken ortho logs using the Ne taffx® (www.af fyme trix.com). 
En sem bl (www.en sem bl.org), a pub lic data base, was used to find 
out the num ber of probe sets used by Af fyme trix for each indi vid-
ual gene or tran script for this spe cific array.
Results
Global gene expres sion pattern in wild­type DT40 and dif fer ent Btk 
mutants
The data sets were ini tially val i dated by the pres ence of inter-
nal con trols, neo my cin phos pho trans fer ase, used for selec tion as a 
positive marker for Btk KO cells and Btk itself as a neg a tive marker 
(Sup ple men tary Fig. 1). The expres sion of neo my cin phos pho trans-
fer ase was influ enced by cell cul tur ing, being reduced 0.3-fold at 
24 h com pared to 6 h of cul ture, while the decreased sig nal from 
the Btk tran scripts did not dif fer sig nifi  cantly (nota bly, tran scripts 
from the trans fec ted human Btk genes are unde tect able by avian 
probe-sets). Unsu per vised clus ter ing showed that the B7.10 and 
the wild-type (WT) B41.13 and kinase-inac tive B46.5 recon sti tuted 
vari ants segregated into the same arm, while the paren tal DT40 
formed its own (Fig. 1). Thus, all KO-derived cell-lines, irre spec-
tive of recon sti tu tion, showed a more sim i lar expres sion pattern as 
com pared to the paren tal DT40 cells. This led us to inves ti gate the 
clonal effect of the pop u la tions used for the array study.
Five hun dred and forty two probe-sets were found dif fer en-
tially expressed between DT40 and B7.10. Those spe cific probe-sets 
were cho sen as selec tion mark ers in order to reveal the spe cific 
expres sion pattern in B41.13 and B46.5, respec tively. A set of 49 
tran scripts, con sist ing of 62 probe-sets, was found to be very sim-
i lar. Among those, Insu lin like growth fac tor 2 mRNA bind ing pro-
tein 3 (IGF2BP3) was up-reg u lated in all the dele tion mutants. On 
the other hand, as many as 48 tran scripts were found down-reg-
u lated at the mRNA expres sion level (Fig. 2; Sup ple men tary Table 
I). Thus, the num ber of tran scripts that was down-reg u lated was 
much higher. The Af fyme trix probe-set ID was used to track the 
total num ber of probe-sets used for those 49 tran scripts, rep re-
sent ing 49 dif fer ent genes pres ent in our expres sion data. Among 
those, IGF2BP3 and USH2A were found sev eral times. Using the 
En sem bl data base for Gal lus gal lus, we iden ti fied 8 tran scripts in 
the cor rect ori en ta tion for USH2A and 4 probe-sets for IGF2BP3 that 
were included on the array. Among those, 4 probe-sets for USH2A 
and 3 probe-sets for IGF2BP3 were affected in our data sets. The 
loca tions of those spe cific probe-sets were iden ti fied and aligned 
along the cor re spond ing gene (Fig. 3). One impor tant obser va tion 
here was that the affected probe-sets behaved in the same way. 
For exam ple, in USH2A, out of the 8 probe-sets, those sig nifi  cantly 
reduced in Btk KO were all located at one end of the gene (Fig. 3). 
This dis tri bu tion was highly sig nifi  cantly dif fer ent (p value = 0.014) 
from a random loca tion of the probe-sets.
The cell-lines were com pared to each other in order to ver ify 
the degree of clonal selec tion among the dele tion mutants. The 
num ber of dif fer en tially expressed tran scripts in each com par i-
son was graph i cally pre sented in the form of “inverse” Venn dia-
grams depict ing non-over lap ping tran scripts (Fig. 4). In DT40 and 
B7.10 com par i sons, the num ber of dif fer en tially expressed tran-
scripts was 903 and 1938 after 6 and 24 h of cul ti va tion, respec-
tively. On the other hand, among the dif fer en tially expressed tran-
scripts between Btk KO (B7.10) cells and such cells recon sti tuted 
with either WT or kinase-inac tive Btk, the num ber was reduced to 
a sim i lar extent. In each com par i son, includ ing both time points, 
fewer tran scripts dif fered as to the num ber in DT40 ver sus B7.10. 
Thus, in the 3 com par i sons made (pan els C and D) an aver age of 
705 and 1158 dif fer en tially expressed tran scripts were found after 
6 and 24 h, respec tively.
Cross­val i da tion of the gene expres sion study
A com par a tive strat egy was taken to cross-val i date the hypoth-
e sis that clonal changes were the ori gin of dif fer en tially expressed 
tran scripts rather than the pres ence or absence of Btk. A list of 
878 dif fer en tially expressed probe-sets was gen er ated with a fold 
change cut-off value of 2 between DT40 and B7.10 after 6 h of cul-
Fig. 1. Clus ter ing pattern of DT40 and Btk KO mutants. Spe cific pattern of clus ter ing 
among the mutants.
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ture with out any stim u la tion. This list was com pared with the dif-
fer en tially expressed genes between DT40 ver sus B41.13 (referred 
to as com par i son 1) and also with DT40 ver sus B46.5 (com par i son 
2). The num ber of tran scripts was more or less sim i lar at dif fer ent 
fold changes, rang ing from 1.2–2, in both the com par i sons men-
tioned above (Sup ple men tary Table IIA). An in sil ico titra tion graph 
was gen er ated and the num ber of tran scripts that changed grad-
u ally along with the increase in fold change was sim i lar in both 
com par i sons (Sup ple men tary Fig. 2).
We also com pared the anti-IgM stim u lated cells with their 
un-stim u lated coun ter part to detect any sig nifi  cant dif fer ence in 
between them. Sim i lar com par i sons were made in DT40 and B7.10 
cell-lines, where a list of dif fer en tially expressed genes was gen er-
ated. This list of tran scripts was com pared against B41.13 (com par i-
son 3) and B46.5 (com par i son 4), respec tively. The num ber of tran-
scripts that over lapped cor re sponds to the num ber of tran scripts 
that was found in com par i son 1 and 2 (Sup ple men tary Table IIB).
In order to cor re late our results to pre vi ous stud ies, data sets 
were obtained from mouse Btk-defec tive, tran si tional type 1 (T1) 
B-cells [18], and primary splenic B-cells [19], respec tively. Both of 
these stud ies were con ducted using Af fyme trix-based micro array 
chips to iden tify dif fer en tially expressed genes in Btk-defi cient 
B-cells. In both cases, dif fer en tially expressed mouse tran scripts 
in between nor mal and Btk- defec tive B-cells were con verted 
accord ing to the Af fyme trix probe ID into chicken ortho logs. Only 
three probe-sets from the data of Btk-defec tive T1 B-cells and not 
a sin gle one from the data of primary splenic B-lym pho cytes over-
lapped with either Com par i son 1 or Com par i son 2.
Another data set from Btk KO mouse primary spleen B-cells 
[20] was also included for cross-val i da tion. In this study B-lym-
pho cytes, with or with out Btk, and sub se quently stim u lated 
with CpG were used for the com par i son. A list of dif fer en tially 
expressed tran scripts was gen er ated. This list was com pared 
against the chicken data con verted into mouse ortho logs. In the 
mouse CpG data, the num ber of tran scripts over lap ping between 
mouse ortho logs of chicken data was the same as in the original 
com par i son 1. It was also sim i lar in the case of com par i son 2, when 
mouse ortho logs of chicken tran scripts between DT40 and B46.5 
were com pared against the original mouse data. Sim i lar changes 
were also observed fol low ing anti-IgM stim u la tion of chicken cells 
(com par i son 3 and 4) when tran scripts were con verted into mouse 
ortho logs and cross-checked against mouse CpG data sets.
We selected these data sets because the cells used in those 
micro array stud ies were either in rest ing state or acti vated. Com-
par ing our results with data sets from Btk-defec tive T1 B-cells and 
primary splenic B-lym pho cytes (both at rest ing state) revealed 
no sim i lar ity or over lap. As cell-lines are con sid ered more like 
acti vated cells, higher degree of relat ed ness was observed in our 
chicken data when con vert ing the mouse CpG data sets into mouse 
ortho logs and there af ter com par ing them to chicken data. Thus, 
com par i son 1 and 2 in chicken cell-lines revealed an aver age of 62 
tran scripts that were either up- or down-reg u lated. A sim i lar value 
was obtained in the com par i son to CpG-stim u lated mouse cells 
(aver age 64 tran scripts). In con trast, as men tioned, when rest ing 
cells were used in those com par i sons, fewer tran scripts were iden-
ti fied (vide supra).
Influ ence of dif fer ent fetal calf serum batches on expres sion pro fil ing
Three dif fer ent batches of fetal calf serum were ran domly cho-
sen to study their effects on the cell-lines. It is known that cells 
show var i able growth pattern using dif fer ent batches of serum, 
but the extent of var i a tion as mea sured as expres sion pro fil ing 
has to our knowl edge not been addressed before. In order to 
inves ti gate the expres sion data, we com pared the influ ence of 
the three dif fer ent batches (assigned as 1, 2 and 3) of fetal calf 
serum that were used to sup ple ment the DT40 and B7.10 cell-
lines. Clus ter den dro gram of the 20 sam ples that were used for 
the study of influ ence of fetal calf serum batches showed that dif-
fer ent batches did not clus ter together. Instead, they segregated 
ran domly with out a defi  nite clus ter ing pattern (Sup ple men tary 
Fig. 3) with a p value >0.05.
Dis cus sion
Gene expres sion pro fil ing using micro array has been con sid-
ered as one of the most valu able tools in molec u lar biol ogy in 
recent days. The chicken lym phoma cell-line DT40 has been exten-
sively used owing to its pro pen sity for the gen er a tion of dele tion 
mutants (a Med line search Octo ber 2, 2008 iden ti fied 559 Refs.). 
These cells have served as a highly use ful model for the study of 
prox i mal sig nal ing events. It has been pre vi ously dem on strated 
that chicken KO cells recon sti tuted with a human BTK gene have 
the same func tional activ ity as paren tal DT40 cells, when ana lyz-
ing mem brane-prox i mal sig nal ing events [21,22]. The aim was to 
study the effect of a sin gle-gene muta tion in a cell-line and sub-
se quently, the effect of the gene recon sti tu tion. Thus, sub-lines of 
Btk KO DT40 cells recon sti tuted with human WT Btk as well as 
kinase-inac tive Btk were stud ied. How ever, in con trast to prox i-
mal events, we observed that when tran scrip tional pat terns were 
inves ti gated, clonal selec tion is sug gested to be the dom i nant 
under ly ing fac tor.
Fig. 2. Expres sion pro fil ing of DT40 and Btk KO mutants. Heat map show ing the 
expres sion pattern of the 49 genes, cor re spond ing 62 probe-sets, found sig nifi  cantly 
changed among all B7.10 and B7.10-recon sti tuted sub-clones com pared to paren tal 
DT40. (A = DT40, B = B7.10, D = B41.13, E = B46.5; 1, 2 and 3 are dif fer ent batches of 
fetal calf serum; S = Stim u lated cells and C = Con trol, non-stim u lated cells. The num-
ber at the end cor re sponds to the num ber of hours dur ing which the cells were cul-
ti vated for (2, 6 and 24 h respec tively). *show ing IGF2BP3 and $show ing USH2A with 
their cor re spond ing probe-sets.
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In most of the micro array stud ies of gene defects, a list of dif-
fer en tially expressed genes can be obtained when com par ing a WT 
and a gene KO cell pop u la tion. How ever, in cell-lines it is rather dif-
fi cult to pre dict whether all of those dif fer en tially expressed genes 
are sec ond ary to the spe cific gene knock out. A way to ver ify is to 
recon sti tute the KO pop u la tion with the deleted gene. We observed 
that there was substantial dif fer ence in the expres sion pattern 
between DT40 and B7.10 cells. How ever, the human Btk-recon sti-
tuted B41.13 was more sim i lar towards its paren tal cell-line (Btk 
KO B7.10) than towards DT40 cells. The same effect was observed 
in Btk KO cells recon sti tuted with kinase-inac tive human Btk. It 
is likely that this reflects the much higher degree of clonal selec-
tion, which takes place dur ing the gen er a tion of dele tion mutants 
as com pared to cell-lines recon sti tuted by trans fec tion.
Five hun dred and forty two tran scripts were found to be sig-
nifi  cantly up-or down-reg u lated when DT40 was com pared to 
B7.10. 49 genes behaved the same in all three Btk KO mutants, irre-
spec tive of whether they were recon sti tuted or not. Among those, 
Fig. 4. Dif fer en tially expressed tran scripts. “Inverse” Venn dia gram show ing num ber of dif fer en tially expressed tran scripts in DT40 and the Btk KO mutants. 903 and 1938 
tran scripts dif fer in between DT40 and B7.10 after 6 (panel A) and 24 h (panel B) of cul ti va tion respec tively. Panel C and D shows the num ber of tran scripts that dif fer among 
the Btk KO mutants in those same time points.
Fig. 3. Loca tion and sig nals from probe-sets for USH2A altered in the expres sion study. Tran script align ment shows loca tion of the 8 probe-sets for the USH2A gene, where the 
4 altered tran scripts is in italic (panel A). In panel B, bar-plot show ing sig nal inten si ties of the 8 probe-sets used by Af fyme trix for USH2A in the expres sion data. (A = DT40, 
B = B7.10, D = B41.13, E = B46.5; 1, 2 and 3 are dif fer ent batches of fetal calf serum; S=Stim u lated cells and C = Con trol, non-stim u lated cells. The num ber at the end cor re sponds 
to the num ber of hours dur ing which the cells were cul ti vated for 2, 6 and 24 h, respec tively).
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the level of Insu lin like growth fac tor2 mRNA bind ing pro tein 3 
(IGF2BP3) was found up-reg u lated in all the dele tion mutants. A 
ratio of 48:1 is com pat i ble with the fact that random muta tions 
are expected to mainly induce changes caus ing loss-of-func tion. 
More over, using micro array anal y sis, detect able loss-of-func tion 
only reflects reduc tion at the mRNA level caused by stop-codon 
for ma tion in the 59-end of a gene. For these rea sons we believe 
that if loss-of-func tion effects were mea sured at the pro tein level, 
the alter ation would be even more pro nounced.
More over, an inter nal val i da tion of our pre dic tions comes from 
the fact that the same tran scripts were iden ti fied using inde pen-
dent probe-sets and the fur ther anal y sis of these. Thus, mRNA from 
the sin gle gene with increased expres sion, IGF2BP3, was iden ti fied 
thrice, whereas among those with reduced expres sion, Ush er in 
syn drome 2A and Sor bin and SH3 domain con tain ing 2 were iden-
ti fied by 8 and 3 probe-sets, respec tively. For the USH2A, the loca-
tion of tar get sequences of the cor re spond ing probe-sets showed 
a non-random dis tri bu tion. Thus, they formed an unin ter rupted 
probe-clus ter. This dis tri bu tion is com pat i ble with a sin gle dele tion 
encom pass ing a con tig u ous stretch of the gene. How ever, owing 
to that 3 probe-sets iden ti fy ing RNA tran scribed in the oppo site 
direc tion were not affected, it is more likely that a non-dele tion 
muta tion is the under ly ing cause. It is inter est ing to note that there 
is no men tion ing of the pos si bil ity of clone selec tion bias in a pre-
vi ous pub li ca tion on expres sion pro fil ing of gene-inac ti vated DT40 
cells [23], while we believe that it is likely to be a gen eral phe nom-
e non in gene-mod i fied cell-lines, owing to the pre-exist ing clonal 
var i abil ity. Thus, in con trast to gene prod uct-related prox i mal 
events, where the out come of germ-line muta tions in mice fre-
quently resem ble the effect in DT40 cells, alter a tions of the avian 
tran scrip tome may instead pre dom i nantly be sec ond ary to clonal 
events unre lated to the deleted gene.
How ever, one param e ter known to be of impor tance for DT40 
cells is the expres sion of sur face IgM, since the level may change 
over time [24]. Owing to that, this param e ter was not care fully 
mon i tored in this study, we can not rule out that this could have 
influ enced our results. Future stud ies ana lyz ing cell-lines of other 
ori gins may shed fur ther light on the under ly ing mech a nism.
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Abstract
Background: A central question within biology is how intracellular signaling pathways are maintained throughout
evolution. Btk29A is considered to be the fly-homolog of the mammalian Bruton’s tyrosine kinase (Btk), which is a non-
receptor tyrosine-kinase of the Tec-family. In mammalian cells, there is a single transcript splice-form and the corresponding
Btk-protein plays an important role for B-lymphocyte development with alterations within the human BTK gene causing the
immunodeficiency disease X-linked agammaglobulinemia in man and a related disorder in mice. In contrast, the Drosophila
Btk29A locus encodes two splice-variants, where the type 2-form is the more related to the mammalian Btk gene product
displaying more than 80% homology. In Drosophila, Btk29A displays a dynamic pattern of expression through the embryonic
to adult stages. Complete loss-of-function of both splice-forms is lethal, whereas selective absence of the type 2-form
reduces the adult lifespan of the fly and causes developmental abnormalities in male genitalia.
Methodology/Principal Findings: Out of 7004–7979 transcripts expressed in the four sample groups, 5587 (70–79%) were
found in all four tissues and strains. Here, we investigated the role of Btk29A type 2 on a transcriptomic level in larval CNS
and adult heads. We used samples either selectively defective in Btk29A type 2 (Btk29AficP) or revertant flies with restored
Btk29A type 2-function (Btk29A(fic Exc1–16)). The whole transcriptomic profile for the different sample groups revealed Gene
Ontology patterns reflecting lifespan abnormalities in adult head neuronal tissue, but not in larvae.
Conclusions: In the Btk29A type 2-deficient strains there was no significant overlap between transcriptomic alterations in
adult heads and larvae neuronal tissue, respectively. Moreover, there was no significant overlap of the transcriptomic
changes between flies and mammals, suggesting that the evolutionary conservation is confined to components of the
proximal signaling, whereas the corresponding, downstream transcriptional regulation has been differentially wired.
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Introduction
The evolution of gene expression is considered to mainly result
from regulatory, rather than coding, mutations causing phenotypic
differences [1]. Analyzing six different organs from ten different
species it was recently reported that the rate of gene expression
evolution varies among organs, lineages and chromosomes [2]. As
gene products commonly function together in distinct combina-
tions to fulfill specific tasks, concerted expression changes of
selected genes may be relevant to the survival of the species. Along
these lines of arguments, Brawand et al. described sets of different
organ-specific modules, which were evolutionarily conserved [2].
In this study we have investigated the evolution of tyrosine kinase-
based signaling, focusing on Bruton’s tyrosine kinase (BTK) in
particular. While it is known that elements in proximal BTK-
signaling are conserved even among distantly related species, it
remains an open question as to whether this is also true for the
entire pathways down to the effector level. Here we address this
question at the transcriptomic level.
The sequence of Btk has been conserved throughout evolution,
with an ancestor emerging already prior to the evolution of
metazoans [3]. This kinase belongs to the Tec family of non-
receptor tyrosine kinases (TFKs). While insects have only a single
TFK, in vertebrates there are several kinase species, which have
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e35640
evolved through gene duplications. The fly kinase is most
homologous to vertebrate Btk. However, in spite of the high
degree of sequence conservation, the functional role of Btk seems
to vary throughout evolution. In higher organisms, such as
humans and other mammals, the significance of Btk lies in its
function for a normal development of the immune system [4].
In the absence of mammalian Btk, B-cell receptor signaling is
insufficient for the generation of mature B-lymphocytes [5,6,7],
resulting in the immunodeficiency disease X-linked agammaglob-
ulinemia (XLA) in humans [8,9] and X-linked immunodeficiency
disease (Xid) in mice [10,11]. Insects, like Drosophila, possess neither
B- nor T-cells. An orthologous function for Drosophila Btk, i.e.,
regulating B-cell maturation, can therefore not be expected. The
Drosophila Btk29A locus produces two different gene products, type
1 and type 2, respectively, by differential splicing. The type 2 form
reveals the highest homology to human BTK among mammalian
TFKs [12]. Thus, this variant is considered to be the fly homolog
of Btk by means of protein sequence [3,13]. It is specifically
required for longevity and for development of male genitalia in the
fly [12].
The type 1 splice variant is shorter at the N-terminus and is
unique to flies [3,12]. The Drosophila Btk29A locus displays a
dynamic pattern of expression through the embryonic to adult
stages [FlyAtlas. http://130.209.54.32/atlas/atlas.cgi [14]. The
Btk29AficP is a unique allele in that it is devoid of transcription of
the type 2 isoform, while leaving the type 1 isoform intact. Btk29A
types 1 and 2 are both expressed in the central nervous system
(CNS) and in the imaginal discs [12], which are epidermal
thickenings in the larvae containing ecto- and mesodermal cells,
which give rise to the adult organs during metamorphosis.
Complete loss of function of the gene (i.e., loss of both types 1
and 2) in female germline cells, produced by using the dominant-
female-sterile, FLP/FRT technique, results in oocyte undergrowth
and subsequent embryonic death accompanied by defective head
involution [15,16,17,18,19]. Offspring with selective loss of the
type 2 transcript are viable, developing malformed male genitalia
and a reduced adult life span [12]. Thus, the Btk29A locus exerts
pleiotropic functions both through distinct spatio-temporal riming
of expression as well as the generation of distinct forms of protein
products by alternative splicing in various tissues. When Btk29A
function is lost in a Src64 mutant background, cellularization
becomes incomplete in the blastoderm-stage embryo [20] and late-
staged embryos fail to complete dorsal closure [21]. In Btk29A
mutant females, oogenesis is underdeveloped presumably due to
deficits in the formation of ring canals that transfer cytoplasm from
nurse cells to oocytes [15,16,22]. Both the cellularization and
oocyte phenotypes appear to result from failure to activate actin–
myosin contractions [20]. Chandrasekaran and Beckendorf et al.
have shown that Btk29A controls both the actin cytoskeleton and
the cell cycle in the morphogenesis of embryonic salivary glands
[23]. Interactions between mammalian Btk and actin have also
been reported in several settings [24,25,26,27,28], suggesting this
to be a common denominator in the proximal part of the Btk-
signaling pathway, i.e. proximal of the Btk-dependent transcrip-
tional regulation.
In the present study we adopted a genome-wide approach to
identify Btk-dependent targets in neuronal tissues by exploring the
transcriptional output from Btk-deficient and wild-type tissues, for
two developmental stages in Drosophila melanogaster, respectively.
Genes identified in this way could be direct or indirect targets for Btk-
regulated transcription and outline part of the transcriptomic role
of Btk in the development of the fly. The identification of Btk
targets, corroborated by statistical analyses and gene set enrich-
ment analyses, reveals parts of the scope and complexity, which
Btk plays in the fly. We also conclude that there is no significant
functional transcriptomic conservation for Btk targets between
mouse B-cells and neuronal tissue from Drosophila.
Results and Discussion
We performed transcriptional profiling of the central nervous
system (CNS) tissues from mutant (Btk29AficP) and revertant
(Btk29Afic exe1–16) adults and larvae using the Affymetrix Drosophila
Genome 2 chips, with 18,880 probe sets covering around 13,500
genes. This analysis yielded a list of affected genes known to
function in longevity and aging, two biological processes impaired
in Btk29AficP mutants, thus validating the experimental rationale
and setup. Although the phenotype-genotype association in the
8276k 8277k 8278k 
P-element 
Type 1 
Type 2 
GCAGGCGTCGAGCGC ….GTCGAGCGCTTCTCAG  
Figure 1. P-element insertion point detection: Schematic figure showing P-element transposon P(BmD-w) insertion site. Sequencing results
shows P-element insertion site (arrow) within the genomic DNA of Btk29A at 2L: 8277721. GTCGAGCGC repeats can be seen at both end of the P
insertion, which is a characteristic mark of transposon insertion. This information was further use to distinguish between mutant and revertant flies. In
mutant flies this breakpoint was easily detected in amplicons (Materials and Methods), whereas the revertant did not show any P insertion.
doi:10.1371/journal.pone.0035640.g001
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Drosophila Btk29A locus has been studied in some detail, the
components and regulators of Btk29A signaling remain unex-
plored on the global transcriptomic level. Also, the biological
processes triggered by Btk signaling defects in Drosophila are less
well understood. Moreover, to our knowledge, the comparison of
changes in gene expression profiles between Btk mutants of
different animal species has not been performed before. Here, we
use the strength of the Drosophila system in order to identify
candidate effectors that take part in the Btk signaling process and
use these data to perform an inter-species comparison of Btk-
dependent components between mouse and fruit fly. To achieve
this we have made use of the Btk29A type 2 mutant (Btk29AficP) and
a revertant strain (Btk29A(fic Exc1–16)) where wild type gene function
has been restored by a jump-out event of the mutagenic P-element
from the Btk29AficP chromosome. This revertant fly is considered
to be the most accurate wild type control for the mutant as wild-
type development and life expectancy are fully restored and with
the exception of the P-element, the Btk29A-carrying chromosome
is the same for the two strains [13].
Verifying P-element Insertion Point and the Nature of the
Reversion
In order to define molecularly the experimental flies, we initially
determined the exact location of the P-element insertion. For this
we made use of P-element-specific primers (directed outwards
from both the 59 and 39-ends of the P-element) for Btk29AficP and
eight primers ,500 bp apart, covering in total a stretch of 4 kb
along the genomic sequence of the Btk29A locus. Using PCR,
amplicons were detected for both ends of the P-element. The PCR
products were sequenced and the results showed that the P-
element point-of-insertion into the genomic sequence was at
nucleotide 2L: 8,277,721 (Figure 1). This indicates that the P-
element sits within the Btk29A locus, although its location deviates
for 866 bp from that given in FlyBase (http://flybase.org/)
showing 2L:8,276,855.8,280,039 [-]. The relevant genomic primer
pair produced a PCR-product from Btk29A fic exe 1–16 revertant
genomic DNA, which upon sequencing showed the P-element to
having left the locus by perfect excision, leaving only the wild-type
genomic sequence (data not shown).
Transcriptional Profiling
The transcriptional profiles were analyzed with Affymetrix
whole genome arrays (GeneChip Drosophila Genome 2.0) by a
comparative approach between the ‘‘mutant’’ and ‘‘revertant’’
sample groups for either larvae or adult heads. Thus, in total, 4
different sample groups were collected (Figure 2A–C). To
reconstruct strain and tissue trends in a global transcriptomic
detail, we built an expression distance matrix for the four sample
groups with its replicas and reconstructed a gene expression tree
(Figure 2A). The tree is highly consistent with the expectation that
Figure 2. Global patterns of gene expression differences among sample groups: A) Hierarchical clustering: Neighbor joining tree based
on pairwise distance matrices (12r, Spearman correlation coefficient) for the different sample groups within this study. Sample groups fall out based
on the strongest factor, larval CNS or adult head, respectively, i.e. developmental stage. Thereafter on either Btk29AficP (red) or revertant (Btk29A(fic
Exc1–16)) (green). B) Factorial map of the principal-component analysis: The replicates within each sample collection are grouped together based on
the individual samples whole genome expression profile. Revertant is denoted with D and ficP with a o. All samples are colored individually. The
proportion of the variance explained by the principal components (axis) is indicated in parentheses in the graph. C) Sample correlation matrix:
Spearman correlation (R2) is calculated and visualized by color (red-blue) in the matrix. Within the replicates for the individual sample groups the
correlation is higher than between the sample groups. Also, the correlation within developmental stage was found to be higher compared to
between mutant strains. Sample names are color-coded with red (Btk29AficP) and green (revertant).
doi:10.1371/journal.pone.0035640.g002
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Figure 3. Number of differentially expressed transcripts in Btk defective flies: A differential fold-change cut-off of the Signal Log Ratio
(SLR) .1,2 (difference of means between Btk29AficP and revertant (Btk29A(fic Exc1–16)) was applied to define genes whose expression was significantly
different from that of the revertant and Btk29AficP. Bar-graph showing the number of up- and down-regulated transcripts, respectively, in adult head
and larval CNS after the pair-wise comparison of revertant (Btk29A(fic Exc1–16)) and Btk29AficP data.
doi:10.1371/journal.pone.0035640.g003
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the predominant factor to characterize the profile is the tissue
type/developmental stage followed by the Btk-genotype. A quality
measure for the data input is that the majority of replicates fall
within the respective sample group (Figure 2A–C). To obtain an
initial overview of the transcriptional expression patterns, we
performed a principal-component analysis, which clearly separates
the data according to sample group (Figure 2B). Figure 2C
represents a Pearson correlation (R2) matrix for the whole
transcriptomic profile for all samples included in the study. Here
we see a higher intra-tissue correlation between revertant and
Btk29AficP mutant of the same developmental stage compared to
the intra-strain correlation between the two stages/tissues
(Figure 2C).
Under such circumstances, several mathematical approaches
are possible in extracting the genes that behave differently
according to sample groups. When applying an ANOVA filtering
in the comparison between the mutant (Btk29AficP) and revertant
(Btk29A(fic Exc1–16)) results, irrespective of the stage/tissue (larvae
CNS or adult head) using a p-value of 0.05, we found 523
transcripts being statistically different between the Btk29AficP and
the revertant. On the other hand, when considering the stage/
tissue as the decisive factor (regardless of using Btk29AficP or
revertant data) we detected 4489 transcripts being statistically
different between the groups. This indicates, as expected, that the
difference between tissue types or developmental stages in the fly
gives a stronger influence on the transcriptome compared to the
influence of the Btk29AficP mutation. On the other hand, when both
the tissue type (larvae CNS and adult head) and genotype
(Btk29AficP and revertant) are considered as the decisive ANOVA
factors with a p-value ,0.05 we find 391 transcripts being
statistically different between the 4 sample groups. Thus, on a
transcriptomic level there are 391 transcripts that, by these
criteria, are Btk-dependent in Drosophila neuronal tissue develop-
ment, from larvae to adult flies.
A differential fold-change cut-off of Signal Log Ratio (SLR)
.1,2 (difference of means between FicP and revertant) was
applied to define genes whose expression was significantly different
between the revertant and Btk29AficP. The number of transcripts
found to be differentially expressed between the two genotypes was
more than 4 times higher in adult heads (744) as compared to
Cell death
Metabolic process
Gland development
Cell development
Figure 4. GSEA for the 391 Btk-dependent transcripts during Fly neuronal development: Enriched Biological Process clusters within the
list of 391-transcripts (Btk-dependent transcripts during fly neuronal development). Figure 4 should be statistically interpreted as follows: The nodes,
corresponding to different Gene Ontology clusters, are either not colored (white) i.e. not found with statistical power or colored in the scale yellow to
orange, where yellow nodes are found with statistical significance after Bonferroni correction p,0.05 and orange colored nodes are found to be even
more statistically significant after correction, with a p,7*1028. The grey-zoned data highlights statistically enriched clusters of nodes (genes/
transcripts), which all are represented under the manually designated heading e.g. ‘Gland development’ or ‘Cell death’. Due to space limitations in
the main figure (Figure 4) we are not able to list the genes belonging to each grey-zone and cluster. This information is instead found in the Figure
S1.
doi:10.1371/journal.pone.0035640.g004
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larval CNS (167; Figure 3). This suggests that there are more Btk-
dependent transcripts in the head, perhaps also reflecting the fact
that the head is not only composed of neuronal tissue. The
distribution of up- and down-regulated transcripts was approxi-
mately 50% in adult heads. In the larval CNS sample group, the
distribution of differentially expressed genes/transcripts was
approximately 30% up-regulated versus 70% down-regulated,
suggesting that transcriptional loss-of-function is the predominat-
ing feature in the larval CNS of Btk29AficP mutants.
Clustering of Genes and Functional Enrichment
By performing gene set enrichment analysis using Cytoscape
and the plug-in BiNGO we identified different Gene Ontology
(GO) clusters being enriched in the different data sets. For the 391
probe sets indicated to be Btk-dependent during fly neuronal development
we found four major Gene Ontology clusters to be enriched within
this list (Figure 4 and a more detailed view is found in Figure S1
where the corresponding genes are listed to respective statistically
significant nodes). Due to space limitations in the figures we were
not able to enlarge all the titles of the nodes within the figure. We
have instead tried to find commonalities within the grey-zone and
manually put a ‘heading’ for each of these zones in order to give
the reader an overview of the result of the GSEA. In order to see
the node titles (corresponding to Gene Ontology Biological Process
names) the reader can zoom in on the figure and by this be able to
read the text. Amongst these clusters representing Death, Cell
development, Metabolic process and Gland development we find
genes previously linked to Btk function and fly development, thus
validating the approach of our study, but also genes not previously
known to be associated with Btk in the fly. As such, gene set
enrichment analysis suggests that the genes identified reflect a bona
fide response of fly neuronal development to the loss of Btk.
In the larval CNS we find 167 Btk-dependent transcripts being
differentially expressed with an SLR .1.2 between Btk29AficP and
revertant flies. A Gene Set Enrichment Analysis on this set of
transcripts reveals Gene Ontology terms which mirror undiffer-
entiated progenitor cells for the future adult i.e., ‘imaginal’ cells
(Figure 5 and a more detailed view is found in Figure S2 where the
corresponding genes are listed and colored depending on the
direction of the regulation to respective statistically significant
nodes). Indeed, one of the processes showing the highest statistical
score (after correction with the Benjamini-Hochberg algorithm) is
‘Imaginal disc development’ (GO:000744499) with a corrected p-
value ,0.003. Another GO-term, ‘Developmental process’ (for D.
melanogaster), characterized by 42 genes (in our 167 gene list) out of
a total of 117(in the GO ‘Developmental process’ gene list), which
comprises 35.8% of the total number of genes in the GO term and
25% of the genes being differentially expressed in ‘‘larval CNS
Btk29AficP’’.
For the 744 differentially expressed (SLR.1.2) transcripts found
in ‘‘adult head Btk29AficP’’ there is an overrepresentation of the
terms ‘Aging’ (GO:0007568) and ‘Determination of lifespan’
(GO:0008340) (Figure 6 and a more detailed view is found in
Figure S3 where the corresponding genes are listed and colored
depending on the direction of the regulation to respective
statistically significant nodes). These findings were expected as
life span is reduced in Btk29AficP mutants [12,13]. As these Gene
Ontology terms are not found to be enriched in the larval CNS
tissue samples we hypothesize that the reduction of life span, due
to the Btk defect, is manifested later in the life of the fly and
therefore cannot be foreseen at the larval stage. There are no
Gene Ontology terms found to be enriched in both adult heads and
larval CNS from a global transcriptomical point of view. This
potentially indicates that Btk plays somewhat different roles at
these two developmental stages in Drosophila. This is further
supported by the finding that the larval CNS and adult head
sample groups shared only 20 transcripts (corresponding to 20
genes) out of a total of 29 transcripts (corresponding to 25 genes),
whose expression was either up- or down-regulated in Btk29AficP
mutants at both developmental stages, and a half of these genes was
up-regulated and another half was down-regulated (Table 1 and
Table S1). Table S1 mirrors Table 1 in addition to adding the
dimension of every gene’s Gene Ontology term including Gene
Ontology ID. Btk might be more important in adult rather than
larval neural tissues due to the finding of ‘Spindle organization’-
enriched genes, which belong to the Gene Ontology term ‘mitotic
spindle’. Thus, in the adult developmental stage, Btk might play a
role in proliferation of the glia, since there are no neuroblasts in
the adult head. On the other hand, a gene set enrichment analysis
(using the web-based GO tool ‘DAVID’) performed on the above
mentioned 25 genes (Table 1 and Table S1) revealed a statistical
significant overrepresentation of the GO term ‘Behavior’
(GO:0007610), indicating that the Btk defect, independent of the
developmental stage, might be manifested via the biological
process ‘Behavior’ in Drosophila. Another interesting observation
throughout the gene set enrichment analysis was that the number
of down-regulated transcripts predominates independent of data
set introduced, mirroring the loss-of-function nature of Btk29AficP
mutants.
Transcriptional Comparison between Mouse and Fruit fly
Btk-defective Cells
A central question in biology is to what level protein function in
intracellular signaling pathways is conserved through evolution of
species, like e.g. between mammals and insects. For instance, it has
been proven possible to ‘humanize’ the fly by introducing human
genes of interest, including the human BTK gene, and studying
them in an organotypic context [13,29,30]. Previous studies on
components in the JAK/STAT signaling pathway has revealed a
small, but statistically significant, overlap between Drosophila and
mammals at a transcriptomic level [31]. In sea urchins and sea
stars, organisms that diverged from their common ancestor 500
million years ago, a three-gene feedback loop involving Notch-
signaling controls endoderm and mesoderm development in both
overlapping and distinct ways [32]. Furthermore, appendages of
different insects show divergent use of developmental regulatory
genes, including the helix-loop-helix, homeodomain transcription
factor Distal-less [33]. These phenomena have been referred to as
gene regulatory network ‘‘plug-ins’’, in which sub-circuits are
frequently re-deployed during evolution while the internal
Figure 5. GSEA for the 167 Btk-dependent transcripts found in larvae CNS: Differentially expressed transcripts (167) were subjected to
GSEA and enriched clusters were found. Figure 5 should be statistically interpreted as follows: The nodes, corresponding to different Gene Ontology
clusters, are either not colored (white) i.e. not found with statistical power or colored in the scale yellow to orange, where yellow nodes are found
with statistical significance after Bonferroni correction p,0.05 and orange colored nodes are found to be even more statistically significant after
correction, with a p,7*1028. The grey-zoned data highlights statistically enriched clusters of nodes (genes/transcripts), which all are represented
under the manually designated heading e.g. ‘Systems development’ or ‘Regulation of growth’. Due to space limitations in the main figure (Figure 5)
we are not able to list the genes belonging to each grey-zone and cluster. This information is instead found in the Figure S2.
doi:10.1371/journal.pone.0035640.g005
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structure remains the same [34]. Further example of such rewiring
comes from protein kinase A (PKA) catalytic subunit signaling in
the fungus of the genus, Cryptococcus [35]; two sibling species of this
pathogen express two different catalytic subunits of PKA, and
alternative subunits are used in virulence factor production and
mating in each species. It is envisaged that an ancestral PKA
underwent a duplication event leading to the two catalytic subunit
genes, one of which retained its function for the given biological
processes in each species. Whether the ‘‘unused’’ subunit has
undergone neofunctionalization with a novel gain-of-function for
another biological activity is not known, but this example
demonstrates evolutionary reconfiguration of a signaling cascade.
Recently, rewiring of both prokaryotic and eukaryotic signaling
pathways has been achieved using rational design, demonstrating
another aspect of the alteration of signal transduction pathways
[36,37].
Apart from the well-known developmental role in the immune
system, mammalian Btk has been shown to exert two counteract-
ing roles in apoptosis, one as a protector and in the other as an
inducer of apoptosis depending on the context [38,39]. This
reflects the diverse role of a protein within a species. In the fruit fly,
loss of the Btk29A type 2 transcript is compatible with life, as
opposed to loss of both types 1 and 2 of Btk29A, which is
embryonic lethal. However, type 2 mutant flies display reduced life
span as well as malformation of the male genitalia [15,16]. We
have previously published work on Btk-defective mouse B-
lymphocytes using gene expression profiling [40,41]. In order to
identify factors with conserved functions throughout evolution we
conducted an inter-species comparison of the Btk-dependent
transcripts identified in Drosophila against our previous transcrip-
tomic data obtained with mouse Btk-defective Transitional type
1 B-lymphocytes [40]. Figure 7 illustrates the number of
transcripts found to be expressed in every Drosophila sample group
examined and the level of overlap between the assemblies. This
indicates that approximately 30% of the Drosophila genome is
expressed at the time examined in the respective tissues and
strains. In comparison to these numbers, in mammalian B-
lymphocytes [40] we see that 37% of all transcripts in the mouse
genome are expressed at any given time. Figure 8A shows a Venn-
diagram that illustrates the overlap between the differentially
expressed transcripts found in mouse Btk-defective Transitional
type 1 B-cells (a total of 147 regulated genes) and the Drosophila
Btk29AficP adult head (a total of 744 differentially expressed
transcripts). The overlap between the two species is only sixteen
transcripts, corresponding to 13 genes in the Btk-defective mice
found in our previous study [40] having orthologs in the Btk-
dependent transcripts identified in Drosophila (Figure 8B). Of these
16 transcripts only 5 are found to show parallel changes in
Drosophila and mice being either up- or down-regulated in the Btk-
defective strains (denoted as * in Figure 8B). By analyzing the gene
expression profile from Btk-defective flies representing two
different developmental stages and comparing these to mamma-
lian Btk-defective B-cells we conclude that there is no significant
overlap in the transcriptome for Btk-defective mammalian B-cells
and neuronal cells from Drosophila. Based on these observations, we
conclude that there is no significant functional transcriptomic
conservation for Btk targets between the mammals and fly species.
Concluding Remarks
Although the upstream signaling protein components of Btk29A
seem to be conserved throughout evolution, the downstream
transcriptional pattern seems not to be comparable between the
fruit flies and mice. The Btk-dependent gene expression profile
seen in mouse transitional type 1 B-lymphocytes from Btk-
defective animals thus differs from the global transcriptomic
signature seen in Btk29A type 2-defective neural tissues from
Drosophila. This is in contrast to JAK/STAT signaling in which
Figure 6. GSEA for the 744 Btk-dependent transcripts found in adult head tissue: Enriched clusters of Biological Processes were found in
the Btk-dependent Adult head tissue analysis and were statistically significant. Figure 6 should be statistically interpreted as follows: The nodes,
corresponding to different Gene Ontology clusters, are either not colored (white) i.e. not found with statistical power or colored in the scale yellow to
orange, where yellow nodes are found with statistical significance after Bonferroni correction p,0.05 and orange colored nodes are found to be even
more statistically significant after correction, with a p,7*1028. The grey-zoned data highlights statistically enriched clusters of nodes (genes/
transcripts), which all are represented under the manually designated heading e.g. ‘Transport’ or ‘Aging and life span’. Due to space limitations in the
main figure (Figure 6) we are not able to list the genes belonging to each grey-zone and cluster. This information is instead found in the Figure S3.
doi:10.1371/journal.pone.0035640.g006
Table 1. 25 genes found to overlap between D. melanogaster
larvae CNS and adult head.
D.melanogaster FlyBase ID Differentially regulated
Gene symbol Btk29AficP Btk29AficP
Adult Head Larvae CNS
w FBgn0003996 4.37 3.49
TpnC47D FBgn0010423 2.22 2.89
A-Est1 FBgn0015568 1.83 2.21
l(3)mbn FBgn0002440 1.39 2.18
CG5597 FBgn0034920 1.36 2.12
CG5023 FBgn0038774 1.28 1.62
CG11807 FBgn0033996 2.92 1.59
CG4398 FBgn0034126 1.91 1.53
pnt FBgn0003118 1.4 1.31
CG2177 FBgn0039902 1.44 1.25
mthl3 FBgn0028956 22.23 21.22
pen-2 FBgn0053198 21.84 21.25
gdl-ORF39 FBgn0028377 21.23 21.4
CG14033 FBgn0046776 22.05 21.4
pst FBgn0035770 21.59 21.56
CG6984 FBgn0034191 21.42 21.65
CG11671 FBgn0037562 22.01 22
CG42254 FBgn0259112 21.79 22.02
CG17264 FBgn0031490 21.72 22.07
CG32368 FBgn0052368 22.9 25.88
CG12241 FBgn0038304 1.46 21.29
Dob FBgn0030607 21.87 1.61
Obp56h FBgn0034475 23.52 2.12
proPO-A1 FBgn0261362 21.64 2.81
CG10176 FBgn0032682 1.22 21.28
Italics denotes down-regulated genes.
*denotes genes differentially expressed NOT in the same regulatory direction
for the larval CNS and adult head sample group.
doi:10.1371/journal.pone.0035640.t001
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Figure 7. Distribution of expressed transcripts in each sample group and their overlaps: Venn- diagram showing the number of
expressed probe-sets of the respective sample group and their overlap. The probe-sets found to be expressed above background (Affymetrix P-calls)
in all three replicates per sample group were considered within this figure.
doi:10.1371/journal.pone.0035640.g007
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Figure 8. Comparison between Mouse and Drosophila Btk-dependent transcript: A) Venn-diagram: showing the overlap between Btk-
dependent Transitional type 1 B-cells from Btk-defective mice [40] (a total of 147 differentially expressed genes) and the Btk-dependent transcripts
found in Btk29AficP Drosophila adult head (a total of 744 differentially expressed genes). B) Thirteen orthologous transcripts found in Btk KO mouse
Transitional type 1 B-lymphocytes and in Btk29A defective flies. Bar-graph showing the 16 transcripts, corresponding to 13 genes, found to be
common in a homology search between the Btk-dependent transcripts found in the Btk KO mouse Transitional type 1 B-cells compared to its healthy
control strain [40] and the current Drosophila Btk29AficP study. Out of these 13 genes, 5 genes showed the same regulatory direction i.e. being up- or
down-regulated in the respective Btk-defective strain (denoted as *).
doi:10.1371/journal.pone.0035640.g008
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both the upstream and downstream components were reported to
be conserved [31].
Indeed, large scale profiling data must be interpreted with
caution and the genes identified here await ultimate proof as to
whether they represent the bona fide effectors of Btk29A-mediated
developmental signaling. Although detailed mechanisms of action
of individual effectors and their roles linked to Btk29A function
remains partially unknown, it is interesting to note that a profile
related to life-span was recognized, suggesting that our transcrip-
tomical mapping approach has effectively identified different
pathways and effectors likely to play roles in Btk signaling and
functioning regarding fruit fly development.
Materials and Methods
Drosophila Melanogaster Strains
w;Btk29AficP/CyO and w1118; Btk29A(fic Exc1–16)/SM1 were
generated in the Yamamoto laboratory (http://www.jst.go.jp/
erato/project/yks_P/yks_P.html). Flies were raised on standard
medium on a 12:12 h L:D cycle, at 23uC and at 55% RH. The
Btk29AficP chromosome was put over the CyO,
P{w[+mC]=ActGFP}JMR1 (source: Bloomington stock center)
balancer using standard crossing schemes. This balancer was later
used for sorting heterozygous (GFP-positive) from homozygous
Btk29AficP mutants (GFP-negative). Btk29A(fic Exc1–16) flies were
kept homozygous viable in stocks.
P-element Breakpoint Determination using PCR
Four kb (2L:8274950,8279050) surrounding the Btk29A-locus
was used as a template to construct 8 forward-, and 8 reverse-
oriented primers covering the entire 4-kb region from both ends
with a 500 bp spacing. Primers were also made for the 39- and 59-
ends of the Btk29AficP -responsible P-element (BmD-w). Both
primers were facing outwards from the P-element. PCR was
performed using ABI GeneAmpTM system 2700 and the insertion
site was determined by sequencing the PCR product (http://www.
eurofinsdna.com ).
Dissection and Sample Preparation
Flies were anaesthetized using CO2, then immediately dissected.
The tissues dissected were the complete heads, severed at the neck
from adult flies and the CNS (developing brain), including the
optic lobes from third instar wandering stage larvae. Tissues were
collected into RLT buffer, pooled and extracted for RNA using
Qiagen RNeasy RNA extraction kit (Qiagen, Valencia, CA, USA).
In total there were 3 replicates for Btk29AficP and Btk29A(fic Exc1–16)
sample groups (the larval CNS and adult heads).
RNA Isolation and Microarray Processing
RNA was extracted and in vitro reverse-transcribed according to
Affymetrix protocol. Quality assurance was provided by using an
Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA,
USA), after RNA extraction and in vitro transcription steps.
Drosophila genome 2 expression arrays were hybridized and read
using standard Affymetrix procedures. Microarrays were run at
the Bionformatics and Expression Analysis core facility (http://
apt.bea.ki.se/index.html) located at Karolinska Institutet, Hud-
dinge (Novum).
Processing of the High-throughput Arrays and Analysis
GeneChip.CEL files were analyzed by using R statistical
programming language, Bioconductor (http://www.
bioconductor.org/), and the affy package. Data were initially
RMA normalized first across the samples and then within each
sample group. RMA normalized data were then scaled to a
common median value. Both raw and pre-processed data is
deposited in GEO (http://www.ncbi.nlm.nih.gov/geo/)
(GSE30627).
Further filtering, within sample group analyses and pair-wise
comparisons were carried out using dChip (https://sites.google.
com/site/dchipsoft/, http://biosun1.harvard.edu/complab/
dchip/) and Microsoft Excel.
For the Venn-diagram (Figure 7), the probe-sets found to be
expressed above background (Affymetrix P-calls) in all three
replicates per sample group were considered within this figure.
Comparison between Btk-dependent Transcripts from
Btk KO Mouse Transitional Type 1 B-cells [40] and Adult
Btk29AficP Drosophila Btk-dependent Transcripts
An inter-species comparison was conducted of the Btk-
dependent transcripts identified in Drosophila, a total of 744 Btk-
dependent transripts were found, compared to our previous
transcriptomic data obtained from mouse Btk-defective Transi-
tional type 1 B-lymphocytes [40], where a total of 147 Btk-
dependent genes were reported as differentially expressed. The
147 genes found to be Btk-dependent in Btk-defective mouse
Transitional type 1 B-cells were investigated for orthologs/
homologs in the Drosophila melanogaster specie. We made use of
the Affymetrix oligonucleotide array comparison to find which
transcripts could be possible homologs (www.affymetrix.com/
analysis/index.affx). The converted orthologs were then compared
with the differentially expressed Btk-dependent transcripts found
in the Drosophila Btk29AficP adult heads.
Gene Set Enrichment Analysis
Enriched GO clusters were analyzed using Cytoscape (http://
www.cytoscape.org/) [26], with the plug-in system BiNGO [27] in
addition to the DAVID web-tool (http://david.abcc.ncifcrf.gov/
home.jsp) [28,29]. The Hyper-geometric Test with Benjamini-
Hochberg False Discovery Rate Correction was chosen for both
the analyses [27].
Supporting Information
Figure S1 Gene Set Enrichment Analysis for Gene
Ontology (biological process) clusters for the 391 Btk-
dependent transcripts during Fly neuronal development
(Figure 4 in manuscript): Enriched Biological Process clusters
within the list of 391-transcripts (Btk-dependent transcripts during
fly neuronal development). The genes belonging to respective
cluster are written next to the grey-zoned areas. For the main
Figure 4, Figure S1 shows the respective genes found for each
cluster (grey-zoned in Figure 4).
(EPS)
Figure S2 Gene Set Enrichment Analysis for Gene
Ontology (biological process) clusters for the 167 Btk-
dependent transcripts found in larvae CNS: Differentially
expressed transcripts (167) were subjected to GSEA and enriched
clusters were found. The genes belonging to respective cluster are
marked in either red (up-regulated) or blue (down-regulated)
depending on the direction of the gene. For the main Figure 5,
Figure S2 shows the respective genes found for each cluster (grey-
zoned in Figure 5). The genes belonging to respective cluster are
marked in either red (up-regulated) or blue (down-regulated)
depending on the direction of the gene.
(EPS)
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Figure S3 Gene Set Enrichment Analysis for Gene
Ontology (biological process) clusters for the 744 Btk-
dependent transcripts found in adult head tissue:
Enriched clusters of Biological Processes were found in the Btk-
dependent Adult head tissue analysis and were statistically
significant. The genes belonging to respective cluster are marked
in either red (up-regulated) or blue (down-regulated) depending on
the direction of the gene. For the main Figure 6, Figure S3 shows
the respective genes found for each cluster (grey-zoned in Figure 6).
The genes belonging to respective cluster are marked in either red
(up-regulated) or blue (down-regulated) depending on the direction
of the gene.
(EPS)
Table S1 Table S1 mirrors Table 1 (25 genes found to overlap
between D. melanogaster larvae CNS and adult head) in addition of adding
the dimension of every gene’s Gene Ontology term including
Gene Ontology ID.
(DOCX)
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Abstract 
 
When evaluating the contribution of different T cell subsets for the immune response, 
many investigators first purify individual populations and subsequently activate them. In 
this study we have also followed this conventional method and compared gene expression 
profiling of mouse CD3+, CD4+ and CD8+ T cells activated with anti-CD3 antibody. By 
using an algorithm-based analysis method, we found 6% of all expressed genes to be 
dependent on CD4+-CD8+ interactions.  Gene set enrichment analysis (GSEA) of these 
genes revealed 22 overrepresented Gene Ontology (GO) Biological processes. Among 
those ‘adaptive immune response’ and ‘lymphocyte/leucocyte mediated immunity’ were 
of interest in the context of T cell activation. We also observed similar expression pattern 
in genes involved in immune response and T cell activation compared to the global 
expression profiling This observation has significant implications, especially when 
comparing gene expression data from different laboratories. 
 
 
 
 
  
 
 3 
Introduction 
Lymphocytes play a key role for the specific immune recognition of pathogens as they 
initiate adaptive immune responses. The interaction between B and T lymphocytes in 
immune responses began to be deciphered in the late 1960s and early 1970s[1]. Several 
in vivo and in vitro methods for obtaining relatively pure populations of T and B cells 
were also established[2]. Subpopulation of both B and T cells were successfully 
separated using different methods [3, 4]. In vitro stimulation of T lymphocytes has been 
frequently used to expand specific cells present at low precursor frequency in vivo[5]. 
However, this technique might not reflect the in vivo situation because of the variable 
efficiency of outgrowth of different T cell sub-populations [6]. Interaction of the 
CD4+/CD8+ lineages in the thymus is a complex process as both subsets arise from 
double-positive thymocytes [7].  Mature T cells thus have the surface phenotype 
CD4+/CD8- or CD4-/CD8+ and their development  is a highly regulated process[8, 9]. In 
vitro activation of both B and T cells has been performed on a regular basis in numerous 
research laboratories and one conventional way is to first separate the cells and activate 
them thereafter, using different stimuli [10-13]. Since the late 1990s, scientists have 
investigated changes in the percentage and state of activation of CD4+ and CD8+ T cells 
within efferent lymph draining antigen-stimulated peripheral lymphnodes and found that 
they have a greater percentage of CD4+ cells and consequently a higher CD4 : CD8 ratio 
than peripheral blood [14, 15], whereas the  percentage of CD8+ cells is approximately 
equal in all four lymphocyte compartments in efferent lymph, afferent lymph, lymphoid 
tissue mononuclear cells and  peripheral blood[16]. In the secondary lymphoid organ 
(SLO), the periarteriolar lymphoid sheath (PALS) of the spleen, the paracortex of the 
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lymph nodes and the interfollicular zone of Peyer’s patches are collectively known as T 
cell zones [17]. They are densely packed with CD4+ and CD8+T cells and are 
sporadically scattered. Very little has been known so far whether these cells are in direct 
contact or not, but cytokines produced by these cells play a major role when it comes to 
CD4+ and CD8+ T cell interaction especially in virus infections [18, 19].  
 
However, the influence of CD4+-CD8+ interaction for the establishment of the 
transcriptome still remains rather unexplored. In this study, using CD3+, CD4+ and CD8+ 
T cells, we aimed to illustrate whether there is any difference if the cells are initially left 
un-separated or first separated, and then activated using existing expression data from 
previously conducted microarray studies. We performed an algorithm-based comparative 
analysis of the transcriptional pattern between two T cell subsets (CD4+ and CD8+) and 
the corresponding, un-separated, original CD3+ population with a major focus on immune 
related genes using ‘innateDB’ Immune databases. Among others, we observed a 
significant influence on CD4-CD8 interaction for genes involved in immune response 
and T cell activation as measured at the mRNA level. We also identified differentially 
expressed genes after activation and changes in transcript levels using Gene Ontology 
(GO) analysis [20]. Gene set enrichment analysis (GSEA) [21] also revealed significant 
differences between the distribution of GO terms when the cells are separated first and 
then activated. 
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Materials and methods 
T-cell separation and stimulation 
CD3+, CD4+ and CD8+ T-cells were isolated from pooled suspensions of spleen and 
lymph nodes of C57BL/6 wild type (Wt) mice using a negative selection method. [22]. 
The cells were separated over a MACS column (Miltenyi Biotec) and the cell 
suspensions were incubated with the antibodies in PBS supplemented with 2% FCS. 
Streptavidin beads (BD Pharmingen) were used for negative depletion according to 
manufacturer's instructions. The purity of the cells was assessed by flow cytometry and 
was routinely >90% CD3+, >96% CD4+ and >90% CD8+ T-cells. T cells subsets (CD3+, 
CD4+ and CD8+) were stimulated with anti-CD3 (1 μg/ml) for 24 h in 48-well plates.  For 
each stimulus, at least duplicate samples were used in all but one experiment. For the 
CD3+ T cells, triplicates and for the CD4+ T cells duplicates were collected from Wt 
mice. For the CD8+ T cells, we obtained a single sample from Wt owing to low yield of 
resting. 
 
 
RNA isolation and microarray processing 
Total RNA was extracted according to RNeasy Mini protocol (Qiagen, Valencia, CA, 
USA). The cRNA synthesis and hybridization were performed using Affymetrix 
MOE430 2.0 chips in BEA core facility at Department of Biosciences, Karolinska 
Institutet at Novum, Huddinge, Sweden. In total 10 arrays were analyzed which are 
accessible through the Gene Expression Omnibus (GEO; GSE12466). 
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Data analysis and bioinformatics approach 
The pre-processing of the data was performed using MAS5 algorithm [23] in the 
Affymetrix Expression Array Console [24]. The pre-processed data were filtered upon 
the assessed background Signal criteria that were set to linear signal value of 50. 
Assessment of background noise was based upon the number of ‘Absent call’ in all the 
probe sets. Additional filtering was done after removing the Affymetrix control genes 
designated with suffixes –AFFX. In total 19,112 probe-sets fulfilled the criteria. Further 
analyses were carried out using Subio Platform (http://www.subio.jp/ ). Fold change 
criteria of +/-2 was chosen for differentially expressed genes for each T cell subset. 
 
A curated ‘Immune Gene’ list was obtained from the immunology database innateDB 
(http://www.innatedb.com/resourcesCurationGenes.jsp) where 1,402 innateDB Innate 
Immunity Genes (both human and mouse) have been annotated (dated March 2013) [25]. 
Among those, 483 mouse genes were used for the further analysis. Gene ontology (GO) 
analysis was carried out using web-based tool ‘DAVID’ (http://david.abcc.ncifcrf.gov/ ) 
[26].  Gene set enrichment analysis (GSEA) were exercised using Cytoscape with 
‘BiNGO’ plug-in [27]. Filtering criteria was set for overrepresented GO terms ‘biological 
process’ with a False Discovery Rate (FDR) p>0.05 using Benjamini and Hochberg 
multiple testing correction [28]. 
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Results 
Global gene expression profiling of activated T cell subsets 
Microarray gene expression analysis was carried out to observe the changes taking place 
at the transcriptomic level in T cells that were first separated into CD4+ and CD8+ 
population respectively and then either activated using anti- CD3 antibodies for 24 hours 
or left unstimulated for the same time period. We found that the unstimulated T cell 
subsets were clustered together (Figure 1) regardless if they were separated or not. This 
result implies that the effect of activation on the transcriptome is stronger than the 
differences among the T cell subsets themselves.  
 
An amount of 3,299 transcripts were found to be differentially expressed in the CD3+ 
mixed population after activation, with 1,870 transcripts being down-regulated and 1,429 
transcripts found to be up-regulated. On the other hand, in separated CD4+ T cells, after 
activation, 3,140 transcripts were found to be differentially expressed with a number of 
1,590 down-regulated transcripts and 1,550 up-regulated transcripts. In CD8+ T cells, 
5,273 transcripts were found to differ with a fold-change of +/- 2 and among those 3,172 
transcripts were found to be down-regulated whereas, 2,101 transcripts were up-
regulated. Thus, the pattern of differential gene expression is similar in all three T cell 
subsets, even if the predominance of down-regulated genes was not found in the CD4+ 
population.  
 
An amount of 887 transcripts were found to be ‘Common’ in all the T cell subsets after 
activation. Only 184 transcripts were found to be uniquely common between CD3+ and 
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CD4+ T cells, whereas the coressponding number was 1,499 transcripts  overlapping 
between activated CD3+ and CD8+ and 991 transcripts between CD4+ and CD8+ T cells 
(Figure 2A). Thus, the relative overlap is similar between separated and unsepated cells. 
 
Further analysis using GSEA shows the distribution of GO terms in T cell subsets (Figure 
2B). 406 GO Biological Process (BP) terms resembling 887 transcripts were ‘common’ 
in all three subsets. In CD3+ and CD4+ T cells, 19 BP terms corresponding to 184 
transcripts were found to be overlapping. This number was much higher in CD3+ and 
CD8+  (265) most probably due to high number of input transcripts (1,499). In CD4+ and 
CD8+ T cells, the number of common BP terms was 48. This distribution was in 
accordance to what we found in global expression profile. In depth analysis of the’ 
common’ 406 BP terms was carried out in order to see the expression patterns in the T 
cell subsets. GO BP terms were randomly selected to cover a more broad context, i.e. 
Metabolic process GO:0008152, Cell cycle  GO:0007049, Apoptotic  process 
GO:0006915, mRNA Transcription GO:0009299 and Translation GO:0006412. In 
‘mRNA Transcription’, the ratio of up-and down-regulated genes was similar in CD3+ 
and CD4+subsets, whereas in CD8+ T cells, the ratio was almost 2:1 (Figure 3 A).  On the 
contrary, the number of down-regulated genes was very low when it comes to BP term 
‘Translation’ but the pattern was similar in all three T cell subsets (Figure 3B). 
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The influence of CD4+ and CD8+ cell interactions  
In order to find out the frequency of transcripts after activation of T cells and if the gene 
expression profile after stimulation was different when cells were cultured as un-
separated (CD4+ and CD8+ together) compared to culture separately, we used a 
hypothesis-based algorithm on the expression data. Around 10,000 probe-sets containing 
7,947 unique genes were selected with pre-defined criteria (see Materials and Methods). 
Signal intensities from CD4+ or CD8+ T cells after stimulation multiplied by the 
correction factor for frequency ( = the percentage of CD4+ and CD8+ cells in the CD3+ 
population (=1.7))[29]. Thus the correction factor was calculated as 0.63 for CD4+ and 
0.37 for CD8+T cells. 
 
Signal intensity of each gene for CD4+ * 0.63 = N, and 
Signal intensity of each gene for CD8+ * 0.37 = M. 
  
If we assume that the signal intensity (the values obtained after removal of background 
noise/signal <50, linear signal value) for gene ‘X’ in activated CD3+, CD4+ and CD8+ T 
cell populations is Z, N and M respectively, then there are two mutually exclusive 
scenarios: 
 
Scenario (A): If, N+M = Z (Interpretation: no influence of one subset on another) 
When, ∑ (N+M)/Z >0.5, or <2  
Or, Scenario (B): If, N+M ≠ Z (Interpretation: there is an influence) 
When, ∑(N+M)/Z <0.5 or >2   
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 We found 7,474 (~94%) genes that fell into Scenario A (no influence of one cell type on 
another), while 462 (~6%) genes were observed in Scenario B (there is an influence of 
one cell type on another). While this demonstrates that for the majority of genes, 
separated versus co-cultivated CD4+ and CD8+ cells show the same result there is a 
population of genes where there is a significant difference. Gene set enrichment analysis 
(GSEA) for those 462 genes using GO Biological processes showed 22 significant BP 
terms (Table 1). Among those ‘adaptive immune response’ and ‘lymphocyte/leucocyte 
mediated immunity’ were of interest in the context of T cell activation. 
 
 
Influence on immune response and T cell activation 
In order to investigate ‘Innate immunity genes’ in T cell subsets upon activation, we 
obtained a list of 483 curated mouse genes in InnatedDB immunology database 
(http://www.innatedb.com/resourcesCurationGenes.jsp) . Out of these, 175 genes fell into 
the category of no influence pre-defined as Scenario A, whereas 18 genes were 
categorized as Scenario B according to our hypothesis-based algorithm. In a separate 
analysis, 89 genes were found to be differentially expressed in un-separated activated 
CD3+ T cells in comparison to the resting state (Figure 4A). Among those, 25 genes were 
up-regulated whereas 64 genes were down-regulated. A similar kind of study in the CD4+ 
and CD8+ T cells populations showed 62 and 109 differentially expressed genes, 
respectively (supplementary table 1). The ratio of up-and down-regulated genes were not 
only similar in the separated T cell subsets but also resembled the global transcriptional 
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profiling as a majority of the genes were found to be down-regulated after activation. 
Using Gene Ontology GO, 31 genes were identified with the BP term ‘T cell activation’ 
in CD3+ mixed population, whereas the corresponding number was 35 for the separated 
CD4+ subset  and 41 genes for the separated CD4+ and CD8+ T cell subset (Figure 4B and 
supplementary table 2).  
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Discussion 
 
Genome-scale transcriptional profiling of T-cell activation has been studied with or 
without co-stimulation by anti-CD28 antibody [30-32]. A ‘Medline’ search dated July 
2013 with search words ‘Activation of CD4+ and CD8+ T cells after separation’ revealed 
128 articles where most of the research laboratories follow the more conventional method 
and separate lymphocytes before activation. In this study, we show that this may not be 
the optimal way since the separated cells show some altered gene expression profile. 
Global expression profiling in mouse T cell subsets showed discrepancy in the number of 
differentially expressed genes in activated CD3+, CD4+ and CD8+ T cells respectively.   
We then exercised a hypothesis-based algorithm on the gene expression data, which 
unveils that 6% of all genes (462) are influenced if they are separated first and then 
activated. Thus, analysing data in two different approaches strengthens our supposition 
when it comes to the context of cultivating T cells in vitro whether it is separated first and 
then activated or the vice versa. 
 
We conducted further down-stream analysis on those 462 genes using GSEA which 
revealed overrepresented 22 BP terms (Table 1). Among those, ‘adaptive immune 
response’ and ‘lymphocyte mediated immunity’ were two of the processes in the context 
of T cell activation and innate immunity as one of our prime interests was to find out if 
there is any altered expression pattern regarding immune response related genes in 
activated T cell subsets. Genes that were included in these biological processes - 
Cd8a,Igha,Gzmb,Swap70,H2-DMa, and Gadd45g. Cd8a is known to be a cell surface 
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glycoprotein found on most cytotoxic T lymphocytes that mediates efficient cell-cell 
interactions within the immune system [33]. Granzyme B (Gzmb), which is expressed by 
cytotoxic T lymphocytes (CTL), is crucial for the rapid induction of target cell apoptosis 
by CTL in cell-mediated immune response [34]. Several well-known genes related with 
immune response and T cell activation like Ifng, Cd44, Ilr4a were also found related to 
various biological processes in this data-set. CD44 is known to be a marker for T cell 
development in the thymus and also an indicative marker for effector-memory T-cells 
[35]. Ilr4a is required for binding of interleukin-4 to the receptor alpha chain, which is a 
crucial event for the generation of a Th2-dominated early immune response [36]. IFNγ is 
the primary cytokine as Th1 cells secrete IFNγ, which in turn causes more 
undifferentiated CD4+ cells (Th0 cells) to differentiate into Th1 cells and is critical for 
innate and adaptive immunity against viral and intracellular bacterial infections and for 
tumor control [37]. Thus, these well-known genes have influence when it comes to cell-
cell interaction if the cells are co-cultivated and then stimulated. This observation might 
bring new insight in the context of in vitro T cell culture. 
 
The roles of CD4+ T cells in CD8+ responses have been re-defined since the recovery of 
CD8+ Treg cells at the end of the primary response as CD4+ help in the development of 
functional CD8 memory [38-40].  A recent comparative genome-scale, transcriptional 
profiling of T-cell activation in the  CD4+ and CD8+subsets and the mixed CD3+ 
populations also showed newly identified immune response genes in the context of 
communication between CD4+ and CD8+ T cells and T cell  activation [41, 42]. We 
obtained a list of 483 curated mouse genes from the immune database innateDB and as 
 14 
per our suggested algorithm, 91 % of these 483 genes that fulfils the selection criteria, 
according our pre-defined algorithm, fell into the category of ‘no influence’. On the 
contrary, 9 % of these genes were considered to have an influence one cell to another 
(CD4+- CD8+). This finding suggests the role of cell-cell interaction in the context of 
innate immunity and to our knowledge it has not thoroughly been addressed in a 
systematic way.  
 
There is no direct evidence regarding whether the CD4+ and CD8+ cells are in physical 
contact with each other. Studies on distribution of porcine T cell subsets showed similar 
number of CD4+ and CD8+T cells in the perifollicular region of the cortex but more CD8+ 
T cells in medullary and cortico-medullary junctions in the lymphnodes. In spleen, CD4+ 
T cells residing in the periarteriolar lymphoid sheath appeared to be more frequent than 
CD8+  T cells [43]. On the other hand, significantly larger fraction of the CD4+ 
lymphocyte population has been reported to be found in Peyer's patches and palatine 
tonsils than in lymph nodes [44]. Recent advances in two-photon microscopy  has 
brought new insights in the context of  the dynamics of immune-cell interactions in living 
tissues [45]. Distinct dynamics in the lymphnodes has been reported during the induction 
of antigen-specific immunity or tolerance using real-time two-photon microscopy [46]. 
Dendritic cells are professional antigen-presenting cells and also play an important role in 
T-cell peripheral tolerance with their unique property of inducing priming and 
differentiation of naïve CD4+ and CD8+ T cells into helper and cytotoxic effectors by 
secreting cytokines [47]. The role of  CD4+ T-cell in promoting primary CD8+ T-cell 
responses as well as establishing functional memory CD8+ T cells has also being shown 
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in various experimental settings [48]. The activated CD8+ T cells showed poor survival 
without CD4+ T cell help during both the primary and secondary responses [49]. 
 
GSEA showed 406 GO Biological Processes that were found to be common between 
CD3+, CD4+ and CD8+ T cell subsets after activation. The BP term ‘Translation’ showed 
a temporal pattern as most of the genes were found to be up-regulated in all three subsets. 
This observation is supported by a previous work where Garcia-Sanz et al., showed 
translational repression during T cell activation [50]. Taken together, our study illustrates 
the interaction of CD4+ and CD8+ T cells, when they are purified or unseparated as CD3+. 
Using expression profiling data, we found that 6% of the transcripts have an influence in 
the communication between CD4+ and CD8+ T cells. However our results suggest a small 
significance of in vitro cultivation of T cell subsets in the CD4+-CD8+ interaction. This 
finding is of general importance, since whenever T cells are cultivated, whether they are 
separated into subsets or not, has no such major influence on the induced transcriptomes. 
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Figure legends 
 
Figure 1: Hierarchical clustering showing distribution of T cell subsets among the sample 
group using Subio platform. Activated T cells subsets are clustered together irrespective 
of separation. (Colour code showing the log intensity of the signal value, red=high 
intensity, blue=low intensity). 
 
Figure 2: Venn diagram A. Number of overlapping transcripts in differentially expressed 
lists in different T cell subsets after activation. B. Number of overlapping GO terms in 
Gene set enrichment analysis (GSEA). 
 
Figure 3: A. Bar graph showing alteration in gene expression for GO term ‘mRNA 
Transcription derived from Gene set enrichment analysis (GSEA) and B. in ‘Translation’. 
 
Figure 4: A. Bar graph showing number of Immune gene in each T cell subsets after 
activation; B. Diagram showing number of genes from the differentially expressed list in 
T cell subsets assigned by GO term ‘T cell Activation’ using DAVID gene ontology tool. 
 
Table 1: List of overrepresented GO Biological processes with corrected P-value in 
scenario B (there is an influence of one cell type on another) along with corresponding 
genes in each group. (Red denotes up-regulation and blue denotes down-regulation 
respectively) 
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 25 
Table 1:  
 
 
GO-
ID 
Description Corrected 
P-value 
Gene symbol 
2250 adaptive immune response 0,0038721 Cd8a  
Gzmb 
Swap70  
H2-DMa  
Gadd45g 
 
 
 
 
  
2460 adaptive immune response 
based on somatic 
recombination of immune 
receptors built from 
immunoglobulin 
superfamily domains 
0,0038721 Cd8a  
Gzmb  
Swap70 
H2-DMa 
Gadd45g 
 
19882 antigen processing and 
presentation 
0,010835 H2-Aa 
Ifng 
H2-DMa 
H2-Eb1 
 
 
 
 
2478 antigen processing and 
presentation of exogenous 
peptide antigen 
0,03683 H2-Aa  
Ifng 
H2-DMa 
 
 
19886 antigen processing and 
presentation of exogenous 
peptide antigen via MHC 
class II 
0,015294 H2-Aa  
Ifng 
H2-DMa 
 
 
2495 antigen processing and 
presentation of peptide 
antigen via MHC class II 
0,015294 H2-Aa  
Ifng 
H2-DMa 
 
 
2504 antigen processing and 
presentation of peptide or 
polysaccharide antigen via 
MHC class II 
0,024212 H2-Aa  
Ifng 
H2-DMa 
 
30330 DNA damage response, 
signal transduction by p53 
class mediator 
0,015294 Ifi204 
Trp53 
Bbc3 
42771 DNA damage response, 
signal transduction by p53 
0,0091253 Ifi204 
Trp53 
 26 
class mediator resulting in 
induction of apoptosis 
Bbc3 
 
8630 DNA damage response, 
signal transduction 
resulting in induction of 
apoptosis 
0,03683 Ifi204  
Trp53 
Bbc3 
 
2443 leukocyte mediated 
immunity 
0,025433 Cd8a 
Gzmb 
Swap70 
H2-DMa 
 
 
 
2449 lymphocyte mediated 
immunity 
0,010846 Cd8a 
Gzmb 
Swap70 
H2-DMa 
 
     
 
35264 multicellular organism 
growth 
0,035873 Ankrd11 
Trp53 
Zfx 
Tnks2 
 
   
 
1779 natural killer cell 
differentiation 
0,026922 Sp3 
Ikzf1 
 
46638 positive regulation of 
alpha-beta T cell 
differentiation 
0,034677 Cd83 
 Ikzf1 
 Il4ra* 
 
 
33138 positive regulation of 
peptidyl-serine 
phosphorylation 
0,020704 Ifng  
Akt2 
Cd44 
 
46637 regulation of alpha-beta T 
cell differentiation 
0,043596 Cd83 
Ikzf1 
Il4ra* 
 
 
1558 regulation of cell growth 0,0044062 Mndal, 
Apbb2 
Trp53 
Htra3** 
Cd44 
Ppan 
Bbc3 
 
 
33135 regulation of peptidyl-
serine phosphorylation 
0,040549 Ifng 
Akt2 
 27 
Cd44 
 
 
28 ribosomal small subunit 
assembly 
0,043824 Rps10 
Rps15 
 
42274 ribosomal small subunit 
biogenesis 
0,0056314 Nob1 
Rps10 
Rps15 
 
 
2246 wound healing involved in 
inflammatory response 
0,0054254 Cd44 
Hif1a 
 
*Up-regulated in CD3+ T cell. ** Up-regulated in CD8+ T cell.          
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Supplementary Table 1: Differentially expressed lists of genes in ‘Innate immune gene’ 
in CD3+ (A), CD4+ (B) and CD8+ (C). (The most 10 up-and down-regulated genes are 
marked with grey shades) 
 
A: 
 
Gene 
symbol 
Entrez 
Gene 
Gene Title Fold Change 
Pros1 19128 protein S (alpha) 13.72431 
Nr4a3 18124 nuclear receptor subfamily 4, group A, member 3 9.137889 
Irf8 15900 interferon regulatory factor 8 7.9287004 
Ddx21 56200 DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 5.1723394 
Tnfrsf9 21942 tumor necrosis factor receptor superfamily, member 9 4.8939753 
Cdk6 12571 cyclin-dependent kinase 6 4.7233734 
Serpinb9 20723 serine (or cysteine) peptidase inhibitor, clade B, member 9 4.4513044 
Pdcd1 18566 programmed cell death 1 3.5218158 
Ddx1 104721 DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 3.4440618 
Ubqln1 56085 ubiquilin 1 3.398982 
Eif4e 13684 eukaryotic translation initiation factor 4E 3.289648 
Cops5 26754 COP9 (constitutive photomorphogenic) homolog, subunit 5 
(Arabidopsis thaliana) 
2.9387605 
Tbx21 57765 T-box 21 2.857089 
Hspa14 50497 heat shock protein 14 2.7411203 
Rxra 20181 retinoid X receptor alpha 2.7168 
Hspd1 15510 heat shock protein 1 (chaperonin) 2.623722 
Scarb1 20778 scavenger receptor class B, member 1 2.6210725 
Tpst1 22021 protein-tyrosine sulfotransferase 1 2.4418108 
Hif1a 15251 hypoxia inducible factor 1, alpha subunit 2.3304186 
Cflar 12633 CASP8 and FADD-like apoptosis regulator 2.2872581 
Gbp2 14469 guanylate binding protein 2 2.2051938 
Tufm 233870 Tu translation elongation factor, mitochondrial 2.1401458 
Map3k7 26409 mitogen-activated protein kinase kinase kinase 7 2.0636647 
Atf4 11911 activating transcription factor 4 2.058319 
Aim2 383619 absent in melanoma 2 0.4985011 
Cbl 12402 Casitas B-lineage lymphoma 0.49138477 
Unc5cl 76589 unc-5 homolog C (C. elegans)-like 0.48212025 
Zc3hav1 78781 zinc finger CCCH type, antiviral 1 0.47195724 
Nfatc3 18021 nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 
3 
0.46377388 
Pik3c3 225326 phosphoinositide-3-kinase, class 3 0.45709905 
Glrx 93692 glutaredoxin 0.44666728 
Tnfrsf1a 21937 tumor necrosis factor receptor superfamily, member 1a 0.4403006 
Samhd1 56045 SAM domain and HD domain, 1 0.4386051 
Rac2 19354 RAS-related C3 botulinum substrate 2 0.4376938 
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Foxo3 56484 forkhead box O3 0.4281101 
S100a10 20194 S100 calcium binding protein A10 (calpactin) 0.42044848 
Ing4 28019 inhibitor of growth family, member 4 0.41375417 
Nfe2l2 18024 nuclear factor, erythroid derived 2, like 2 0.39289626 
Pycard 66824 PYD and CARD domain containing 0.38949293 
Nr3c1 14815 nuclear receptor subfamily 3, group C, member 1 0.37565327 
Stat1 20846 signal transducer and activator of transcription 1 0.36403802 
Elf1 13709 E74-like factor 1 0.34310332 
Inpp5d 16331 inositol polyphosphate-5-phosphatase D 0.3393214 
Atg12 67526 autophagy related 12 0.33638194 
Ifih1 71586 interferon induced with helicase C domain 1 0.3333476 
Grn 14824 granulin 0.33177298 
Trim21 20821 tripartite motif-containing 21 0.32586756 
Zbp1 58203 Z-DNA binding protein 1 0.3198898 
Treml2 328833 triggering receptor expressed on myeloid cells-like 2 0.31267655 
Pklr 18770 pyruvate kinase liver and red blood cell 0.30733898 
Arhgap15 76117 Rho GTPase activating protein 15 0.30332914 
Ifit2 15958 interferon-induced protein with tetratricopeptide repeats 2 0.29759368 
Pla2g4a 18783 phospholipase A2, group IVA (cytosolic, calcium-dependent) 0.29557285 
Aqp3 11828 aquaporin 3 0.28769308 
Rora 19883 RAR-related orphan receptor alpha 0.28195822 
Tsc22d3 14605 TSC22 domain family, member 3 0.2817741 
Ctss 13040 cathepsin S 0.2667402 
Dusp1 19252 dual specificity phosphatase 1 0.26421064 
Anxa2 12306 annexin A2 0.25611457 
Cd97 26364 CD97 antigen 0.25553998 
Akna 100182 AT-hook transcription factor 0.24614528 
Naip2 17948 NLR family, apoptosis inhibitory protein 2 0.24460384 
Il1rl2 107527 interleukin 1 receptor-like 2 0.23999679 
Cxcr3 12766 chemokine (C-X-C motif) receptor 3 0.23075046 
Ikbke 56489 inhibitor of kappaB kinase epsilon 0.22613524 
Itpr3 16440 inositol 1,4,5-triphosphate receptor 3 0.21983248 
Rnasel 24014 ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) 0.21919127 
Ern1 78943 endoplasmic reticulum (ER) to nucleus signalling 1 0.2149797 
Oas2 246728 2'-5' oligoadenylate synthetase 2 0.21007602 
Btk 12229 Bruton agammaglobulinemia tyrosine kinase 0.20821184 
Trib2 217410 tribbles homolog 2 (Drosophila) 0.20576853 
Plec 18810 plectin 0.19965765 
Oas1c 114643 2'-5' oligoadenylate synthetase 1C 0.1971484 
Cyld 74256 cylindromatosis (turban tumor syndrome) 0.19113925 
Nod1 107607 nucleotide-binding oligomerization domain containing 1 0.17759846 
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Oas1a 246730 2'-5' oligoadenylate synthetase 1A 0.16102402 
Ctsb 13030 cathepsin B 0.15992896 
Abcg1 11307 ATP-binding cassette, sub-family G (WHITE), member 1 0.15162231 
Tnfaip8l2 69769 tumor necrosis factor, alpha-induced protein 8-like 2 0.145865 
Tlr1 21897 toll-like receptor 1 0.11134235 
Ddx58 230073 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 0.10940291 
Tecpr1 70381 tectonin beta-propeller repeat containing 1 0.1079904 
Ifit3 15959 interferon-induced protein with tetratricopeptide repeats 3 0.10682104 
Txnip 56338 thioredoxin interacting protein 0.09463819 
Pyhin1 236312 pyrin and HIN domain family, member 1 0.08606364 
Pglyrp2 57757 peptidoglycan recognition protein 2 0.0810056 
Abca1 11303 ATP-binding cassette, sub-family A (ABC1), member 1 0.06897664 
Ifit1 15957 interferon-induced protein with tetratricopeptide repeats 1 0.06884942 
P2rx7 18439 purinergic receptor P2X, ligand-gated ion channel, 7 0.061535567 
 
 
B: 
 
Gene 
Symbol 
Entrez 
Gene 
Gene Title Fold Change 
Pros1 19128 protein S (alpha) 12.3801365 
Tnfrsf9 21942 tumor necrosis factor receptor superfamily, member 9 7.183595 
Plscr1 22038 phospholipid scramblase 1 5.723464 
Scarb1 20778 scavenger receptor class B, member 1 5.40047 
E2f1 13555 E2F transcription factor 1 4.2441173 
Hif1a 15251 hypoxia inducible factor 1, alpha subunit 4.0453978 
Rxra 20181 retinoid X receptor alpha 2.900475 
Traf6 22034 TNF receptor-associated factor 6 2.8435144 
Nampt 59027 nicotinamide phosphoribosyltransferase 2.6458852 
Lgals3 16854 lectin, galactose binding, soluble 3 2.4340785 
Pmaip1 58801 phorbol-12-myristate-13-acetate-induced protein 1 2.275942 
Ptges2 96979 prostaglandin E synthase 2 2.2385283 
Trp53 22059 transformation related protein 53 2.2198038 
Ddx21 56200 DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 2.1691952 
Map3k7 26409 mitogen-activated protein kinase kinase kinase 7 2.1666358 
Tnf 21926 tumor necrosis factor 2.1663227 
Hspa14 50497 heat shock protein 14 2.1332688 
Bid 12122 BH3 interacting domain death agonist 2.0124643 
Bcl3 12051 B cell leukemia/lymphoma 3 0.49710596 
Ly96 17087 lymphocyte antigen 96 0.4940673 
Cflar 12633 CASP8 and FADD-like apoptosis regulator 0.4875447 
Zbp1 58203 Z-DNA binding protein 1 0.484787 
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Nr3c1 14815 nuclear receptor subfamily 3, group C, member 1 0.4804168 
Ifnar1 15975 interferon (alpha and beta) receptor 1 0.47693443 
Unc5cl 76589 unc-5 homolog C (C. elegans)-like 0.47221813 
Ctsb 13030 cathepsin B 0.4586592 
Treml2 328833 triggering receptor expressed on myeloid cells-like 2 0.43873534 
Itch 16396 itchy, E3 ubiquitin protein ligase 0.43145657 
Zc3hav1 78781 zinc finger CCCH type, antiviral 1 0.4311032 
Cltc 67300 clathrin, heavy polypeptide (Hc) 0.40575516 
Dok3 27261 docking protein 3 0.40555874 
Ahr 11622 aryl-hydrocarbon receptor 0.39366692 
Coro2a 107684 coronin, actin binding protein 2A 0.39264557 
Il1rl2 107527 interleukin 1 receptor-like 2 0.38478047 
Il1rl1 17082 interleukin 1 receptor-like 1 0.3832328 
Pltp 18830 phospholipid transfer protein 0.3790714 
Oas3 246727 2'-5' oligoadenylate synthetase 3 0.37848514 
Aqp3 11828 aquaporin 3 0.34386227 
Cyld 74256 cylindromatosis (turban tumor syndrome) 0.3404207 
Oas1c 114643 2'-5' oligoadenylate synthetase 1C 0.33922407 
Chuk 12675 conserved helix-loop-helix ubiquitous kinase 0.3367694 
Naip2 17948 NLR family, apoptosis inhibitory protein 2 0.3356082 
Rnasel 24014 ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) 0.29989034 
Rictor 78757 RPTOR independent companion of MTOR, complex 2 0.28426898 
Mapk14 26416 Mitogen-activated protein kinase 14 0.2787412 
Rora 19883 RAR-related orphan receptor alpha 0.27558288 
Nod1 107607 nucleotide-binding oligomerization domain containing 1 0.2572262 
Plec 18810 plectin 0.25403547 
Rictor 78757 RPTOR independent companion of MTOR, complex 2 0.25264958 
Trib2 217410 tribbles homolog 2 (Drosophila) 0.25035408 
Rora 19883 RAR-related orphan receptor alpha 0.24753278 
Ifit3 15959 interferon-induced protein with tetratricopeptide repeats 3 0.22749074 
Ccr6 12458 chemokine (C-C motif) receptor 6 0.1986626 
Akna 100182 AT-hook transcription factor 0.19638774 
Ikbke 56489 inhibitor of kappaB kinase epsilon 0.18553475 
Irf3 54131 interferon regulatory factor 3 0.1833945 
Rnasel 24014 ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) 0.16128139 
Ddx58 230073 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 0.1545684 
P2rx7 18439 purinergic receptor P2X, ligand-gated ion channel, 7 0.1009478 
Irf7 54123 interferon regulatory factor 7 0.09965712 
Oas1b 23961 2'-5' oligoadenylate synthetase 1B 0.08353805 
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C: 
 
Gene 
Symbol 
Entrez 
Gene 
Gene Title Fold Change 
Pdcd1 18566 programmed cell death 1 16.239805 
Nr4a3 18124 nuclear receptor subfamily 4, group A, member 3 12.760379 
Tnf 21926 tumor necrosis factor 7.7738776 
Ddx21 56200 DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 4.4549575 
Tpst1 22021 protein-tyrosine sulfotransferase 1 4.4405 
Tnfrsf9 21942 tumor necrosis factor receptor superfamily, member 9 34.302475 
Tnfsf11 21943 tumor necrosis factor (ligand) superfamily, member 11 31.460342 
Gbp2 14469 guanylate binding protein 2 3.663119 
Serpinb9 20723 serine (or cysteine) peptidase inhibitor, clade B, member 9 3.581412 
Pik3ap1 83490 phosphoinositide-3-kinase adaptor protein 1 3.5144367 
Ddx1 104721 DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 3.4350262 
Plscr1 22038 phospholipid scramblase 1 3.4169834 
Nampt 59027 nicotinamide phosphoribosyltransferase 3.1733992 
Irf8 15900 interferon regulatory factor 8 28.209078 
Tbx21 57765 T-box 21 2.7896063 
Foxo3 56484 forkhead box O3 2.7538667 
Ubqln1 56085 ubiquilin 1 2.6693857 
Scarb1 20778 scavenger receptor class B, member 1 2.617003 
Cops5 26754 COP9 (constitutive photomorphogenic) homolog, subunit 5 (Arabidopsis 
thaliana) 
2.5603132 
Cflar 12633 CASP8 and FADD-like apoptosis regulator 2.464877 
Eif4e 13684 eukaryotic translation initiation factor 4E 2.4226782 
Hspa14 50497 heat shock protein 14 2.3176851 
Hspd1 15510 heat shock protein 1 (chaperonin) 2.250849 
Tufm 233870 Tu translation elongation factor, mitochondrial 2.2464745 
Map3k7 26409 mitogen-activated protein kinase kinase kinase 7 2.2161098 
Casp7 12369 caspase 7 2.2058234 
March5 69104 membrane-associated ring finger (C3HC4) 5 2.0846524 
Il1b 16176 interleukin 1 beta 2.0652885 
Traf6 22034 TNF receptor-associated factor 6 2.0505247 
Bcl2 12043 B cell leukemia/lymphoma 2 0.49794412 
Dok3 27261 docking protein 3 0.49775374 
Usp4 22258 ubiquitin specific peptidase 4 (proto-oncogene) 0.4959911 
Pacsin1 23969 protein kinase C and casein kinase substrate in neurons 1 0.4954406 
Il1rl2 107527 interleukin 1 receptor-like 2 0.48886737 
Nrip1 268903 nuclear receptor interacting protein 1 0.48659888 
Casp8 12370 caspase 8 0.48656544 
Ifit2 15958 interferon-induced protein with tetratricopeptide repeats 2 0.48382193 
Irak4 266632 interleukin-1 receptor-associated kinase 4 0.46958405 
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Nfatc3 18021 nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3 0.464011 
Eif2ak2 19106 eukaryotic translation initiation factor 2-alpha kinase 2 0.46299917 
Lgals9 16859 lectin, galactose binding, soluble 9 0.46189544 
Nod1 107607 nucleotide-binding oligomerization domain containing 1 0.45942372 
Trim21 20821 tripartite motif-containing 21 0.45827174 
Akt1 11651 thymoma viral proto-oncogene 1 0.4526772 
Tax1bp1 52440 Tax1 (human T cell leukemia virus type I) binding protein 1 0.4464951 
Ikbkb 16150 inhibitor of kappaB kinase beta 0.44294488 
Nr3c1 14815 nuclear receptor subfamily 3, group C, member 1 0.44061738 
Zc3hav1 78781 zinc finger CCCH type, antiviral 1 0.44029713 
Cbl 12402 Casitas B-lineage lymphoma 0.4384928 
Nfe2l2 18024 nuclear factor, erythroid derived 2, like 2 0.43645692 
Pura 19290 purine rich element binding protein A 0.4364379 
Adar 56417 Adenosine deaminase, RNA-specific 0.43621206 
Cd97 26364 CD97 antigen 0.4340961 
Arhgap15 76117 Rho GTPase activating protein 15 0.4304531 
Mapk14 26416 Mitogen-activated protein kinase 14 0.41837218 
Btk 12229 Bruton agammaglobulinemia tyrosine kinase 0.41789111 
Cd300lf 246746 CD300 antigen like family member F 0.41435316 
Inpp5d 16331 inositol polyphosphate-5-phosphatase D 0.41123167 
Ing4 28019 inhibitor of growth family, member 4 0.40929478 
Dusp10 63953 dual specificity phosphatase 10 0.4069025 
Ifnar1 15975 interferon (alpha and beta) receptor 1 0.40334955 
Itch 16396 itchy, E3 ubiquitin protein ligase 0.40263137 
Elf1 13709 E74-like factor 1 0.39930362 
Zc3h12a 230738 zinc finger CCCH type containing 12A 0.39838165 
Ikbke 56489 inhibitor of kappaB kinase epsilon 0.394835 
Ctsb 13030 cathepsin B 0.38660493 
Ltbr 17000 lymphotoxin B receptor 0.38316503 
Lair1 52855 leukocyte-associated Ig-like receptor 1 0.37261263 
Ip6k1 27399 inositol hexaphosphate kinase 1 0.37246168 
S100a10 20194 S100 calcium binding protein A10 (calpactin) 0.37204677 
Akap10 56697 A kinase (PRKA) anchor protein 10 0.36266223 
Naip2 17948 NLR family, apoptosis inhibitory protein 2 0.3561497 
Aim2 383619 absent in melanoma 2 0.3514144 
Pyhin1 236312 pyrin and HIN domain family, member 1 0.3502625 
Irf3 54131 interferon regulatory factor 3 0.3484335 
Cyld 74256 cylindromatosis (turban tumor syndrome) 0.34648833 
Gsk3b 56637 Glycogen synthase kinase 3 beta 0.3425342 
Akna 100182 AT-hook transcription factor 0.3414414 
Ccr6 12458 chemokine (C-C motif) receptor 6 0.322682 
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Stim1 20866 stromal interaction molecule 1 0.3209075 
Cnot4 53621 CCR4-NOT transcription complex, subunit 4 0.3161724 
Aqp3 11828 aquaporin 3 0.3159503 
Rictor 78757 RPTOR independent companion of MTOR, complex 2 0.30611745 
Rora 19883 RAR-related orphan receptor alpha 0.2977626 
Itpr3 16440 inositol 1,4,5-triphosphate receptor 3 0.2975865 
Rnasel 24014 ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) 0.29466242 
Oas1c 114643 2'-5' oligoadenylate synthetase 1C 0.2943554 
Oas1b 23961 2'-5' oligoadenylate synthetase 1B 0.2733997 
Oas2 246728 2'-5' oligoadenylate synthetase 2 0.25806507 
Ern1 78943 endoplasmic reticulum (ER) to nucleus signalling 1 0.2514128 
Abcg1 11307 ATP-binding cassette, sub-family G (WHITE), member 1 0.24762993 
Tecpr1 70381 tectonin beta-propeller repeat containing 1 0.24462765 
Ifit3 15959 interferon-induced protein with tetratricopeptide repeats 3 0.23268622 
Pglyrp2 57757 peptidoglycan recognition protein 2 0.23127589 
Trib2 217410 tribbles homolog 2 (Drosophila) 0.22072867 
Plec 18810 plectin 0.21930467 
Ddx58 230073 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 0.20914766 
Tnfaip8l2 69769 tumor necrosis factor, alpha-induced protein 8-like 2 0.19629578 
Txnip 56338 thioredoxin interacting protein 0.19268131 
Tlr1 21897 toll-like receptor 1 0.17818478 
Nlrc3 268857 NLR family, CARD domain containing 3 0.15994185 
Oas1a 246730 2'-5' oligoadenylate synthetase 1A 0.15550193 
Oas3 246727 2'-5' oligoadenylate synthetase 3 0.14724338 
Treml2 328833 triggering receptor expressed on myeloid cells-like 2 0.1412012 
Ifit1 15957 interferon-induced protein with tetratricopeptide repeats 1 0.13018186 
Abca1 11303 ATP-binding cassette, sub-family A (ABC1), member 1 0.12118901 
Irf7 54123 interferon regulatory factor 7 0.11746269 
P2rx7 18439 purinergic receptor P2X, ligand-gated ion channel, 7 0.09431074 
Tsc22d3 14605 TSC22 domain family, member 3 0.06060853 
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Supplementary Table 2: Differentially expressed lists of genes in ‘T cell activation’ in 
CD3+ (A), CD4+ (B) and CD8+ (C). (The most 10 up-and down-regulated genes are 
marked with grey shades) 
 
A: 
 
Gene Symbol Entrez Gene Gene Title Fold Change 
Zbtb32 58206 zinc finger and BTB domain containing 32 5.1060586 
Gadd45g 23882 growth arrest and DNA-damage-inducible 45 gamma 4.538945 
Stat5a 20850 signal transducer and activator of transcription 5A 3.6064506 
Hspd1 15510 heat shock protein 1 (chaperonin) 2.623722 
1443703_at   2.5738592 
Jmjd6 107817 jumonji domain containing 6 2.4585385 
Fkbp1a 14225 FK506 binding protein 1a 2.1731253 
Blm 12144 Bloom syndrome, RecQ helicase-like 2.1514957 
Ppp3cb 19056 protein phosphatase 3, catalytic subunit, beta isoform 0.48641378 
Stat5b 20851 signal transducer and activator of transcription 5B 0.47643435 
Ncor1 20185 nuclear receptor co-repressor 1 0.44225666 
Myh9 17886 myosin, heavy polypeptide 9, non-muscle 0.41647974 
Satb1 20230 special AT-rich sequence binding protein 1 0.40193048 
Sox4 20677 SRY-box containing gene 4 0.38886943 
Rpl22 100504863 /// 
19934 
60S ribosomal protein L22-like /// ribosomal protein 
L22 
0.37483567 
Smad3 17127 SMAD family member 3 0.37025616 
Dock2 94176 dedicator of cyto-kinesis 2 0.32776883 
H2-M3 14991 histocompatibility 2, M region locus 3 0.31174248 
Hsh2d 209488 Hematopoietic SH2 domain containing 0.29436725 
Itpkb 320404 inositol 1,4,5-trisphosphate 3-kinase B 0.24133293 
Themis 210757 thymocyte selection associated 0.23927073 
Lck 16818 lymphocyte protein tyrosine kinase 0.20723325 
Rhoh 74734 ras homolog gene family, member H 0.19496359 
Ccnd3 12445 cyclin D3 0.17938279 
Sla2 77799 Src-like-adaptor 2 0.17053519 
Card11 108723 caspase recruitment domain family, member 11 0.1485169 
Cd86 12524 CD86 antigen 0.1371939 
5830411N06
Rik 
244234 RIKEN cDNA 5830411N06 gene 0.1005823 
Il7r 16197 interleukin 7 receptor 0.0751177 
P2rx7 18439 purinergic receptor P2X, ligand-gated ion channel, 7 0.061535567 
Cd1d1 12479 CD1d1 antigen 0.055453822 
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B: 
 
Gene Symbol Entrez 
Gene 
Gene Title Fold Change 
Slamf1 27218 signaling lymphocytic activation molecule family member 1 8.749248 
1434279_at  6.5629764 
Blm 12144 Bloom syndrome, RecQ helicase-like 5.676049 
Gadd45g 23882 growth arrest and DNA-damage-inducible 45 gamma 4.3227243 
Rbpj 19664 recombination signal binding protein for immunoglobulin kappa J 
region 
4.1750455 
Eomes 13813 eomesodermin homolog (Xenopus laevis) 3.5600965 
Zbtb32 58206 zinc finger and BTB domain containing 32 3.2836645 
Exo1 26909 exonuclease 1 21.687248 
Stat5a 20850 signal transducer and activator of transcription 5A 2.9683588 
Traf6 22034 TNF receptor-associated factor 6 2.8435144 
Tpd52 21985 tumor protein D52 2.6236224 
Pou2f2 18987 POU domain, class 2, transcription factor 2 2.3865778 
Ercc1 13870 excision repair cross-complementing rodent repair deficiency, 
complementation group 1 
2.3435528 
Trp53 22059 transformation related protein 53 2.2198038 
Dnaja3 83945 DnaJ (Hsp40) homolog, subfamily A, member 3 2.0760431 
Bcl6 12053 B cell leukemia/lymphoma 6 0.49855477 
Bcl3 12051 B cell leukemia/lymphoma 3 0.49710596 
Ifnar1 15975 interferon (alpha and beta) receptor 1 0.47693443 
1442617_at  0.4578828 
Unc13d 70450 unc-13 homolog D (C. elegans) 0.44653553 
Pik3cd 18707 phosphatidylinositol 3-kinase catalytic delta polypeptide 0.434327 
Mll5 69188 myeloid/lymphoid or mixed-lineage leukemia 5 0.38439572 
Clcf1 56708 cardiotrophin-like cytokine factor 1 0.32848728 
Sla2 77799 Src-like-adaptor 2 0.32388505 
Skap2 54353 src family associated phosphoprotein 2 0.31942636 
Cd86 12524 CD86 antigen 0.2755583 
Cxcr5 12145 chemokine (C-X-C motif) receptor 5 0.2720764 
Lax1 240754 lymphocyte transmembrane adaptor 1 0.26196453 
Pik3r1 18708 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 
(p85 alpha) 
0.19818771 
Sbno2 216161 strawberry notch homolog 2 (Drosophila) 0.18271326 
Themis 210757 thymocyte selection associated 0.17829123 
5830411N06Ri
k 
244234 RIKEN cDNA 5830411N06 gene 0.16991177 
Ccnd3 12445 cyclin D3 0.1490088 
Lck 16818 lymphocyte protein tyrosine kinase 0.13601607 
P2rx7 18439 purinergic receptor P2X, ligand-gated ion channel, 7 0.1009478 
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C: 
 
Gene Symbol Entrez Gene Gene Title Fold Change 
Blm 12144 Bloom syndrome, RecQ helicase-like 4.551019 
Gadd45g 23882 growth arrest and DNA-damage-inducible 45 gamma 4.341037 
Cd28 12487 CD28 antigen 3.589423 
Fkbp1a 14225 FK506 binding protein 1a 3.0457816 
Psen1 19164 presenilin 1 2.3035903 
Hspd1 15510 heat shock protein 1 (chaperonin) 2.250849 
Dnaja3 83945 DnaJ (Hsp40) homolog, subfamily A, member 3 2.1950712 
Jmjd6 107817 jumonji domain containing 6 2.1394832 
Zbtb32 58206 zinc finger and BTB domain containing 32 19.175894 
Bcl2 12043 B cell leukemia/lymphoma 2 0.49794412 
Apc 11789 adenomatosis polyposis coli 0.49776313 
Atp7a 11977 ATPase, Cu++ transporting, alpha polypeptide 0.49527687 
Prkdc 19090 protein kinase, DNA activated, catalytic polypeptide 0.48708066 
Dock2 94176 dedicator of cyto-kinesis 2 0.48291415 
Bcl11b 58208 B cell leukemia/lymphoma 11B 0.47466266 
Smad3 17127 SMAD family member 3 0.47357482 
Ncor1 20185 nuclear receptor co-repressor 1 0.47129598 
Ptprc 19264 Protein tyrosine phosphatase, receptor type, C 0.46320382 
Ppp3cb 19056 protein phosphatase 3, catalytic subunit, beta isoform 0.4417437 
Stat5b 20851 signal transducer and activator of transcription 5B 0.4247084 
H2-DMa 14998 histocompatibility 2, class II, locus DMa 0.4131365 
Ifnar1 15975 interferon (alpha and beta) receptor 1 0.40334955 
Myh9 17886 myosin, heavy polypeptide 9, non-muscle 0.4006346 
Sox4 20677 SRY-box containing gene 4 0.38668674 
Themis 210757 thymocyte selection associated 0.38636786 
Gm15472 100503170 predicted gene 15472 0.38031948 
LOC100504863 /// 
Rpl22 
100504863 /// 
19934 
60S ribosomal protein L22-like /// ribosomal protein 
L22 
0.37140003 
Hsh2d 209488 Hematopoietic SH2 domain containing 0.34332898 
Rhoh 74734 ras homolog gene family, member H 0.29548007 
Card11 108723 caspase recruitment domain family, member 11 0.27250442 
Itpkb 320404 inositol 1,4,5-trisphosphate 3-kinase B 0.26633596 
Ccnd3 12445 cyclin D3 0.22779824 
Cd1d1 12479 CD1d1 antigen 0.17777559 
Nlrc3 268857 NLR family, CARD domain containing 3 0.15994185 
Cd86 12524 CD86 antigen 0.15750249 
Sla2 77799 Src-like-adaptor 2 0.12787358 
Lck 16818 lymphocyte protein tyrosine kinase 0.11883396 
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Satb1 20230 special AT-rich sequence binding protein 1 0.09969395 
P2rx7 18439 purinergic receptor P2X, ligand-gated ion channel, 7 0.09431074 
5830411N06Rik 244234 RIKEN cDNA 5830411N06 gene 0.0869558 
Il7r 16197 interleukin 7 receptor 0.08614151 
 
 
 
 
 
  
